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A STUDY ON SANGAN VERPATTAI CHOORANAM 
INTRODUCTION  
TAMIL SIDDHA SYSTEM OF MEDICINE  
 The word siddha derived from the word ‘Siddhi’ which means ‘an 
object to be attained (or) ‘perfection’ or ‘heavenly bliss’. Siddhi 
generally, refers to Astama Siddhi  (m];lkhrpj;jp) that is the eight great 
supernatural powers which are enumerated as Anima, Magima, Legima, 
Karimma, Prapthi, Prakamiyam, Vasithuvam and Easathuvam.  
Those who attained or achieved the above said powers are known as 
siddhers.  
The Siddhers were a class of popular writers on Tamil in all 
Branches of Knowledge and many of their works were written in the style 
of ancient Tamil.  The Kavi (or) poetry written in medical and other 
scientific approaches are composed.  These are administered by the 
workers who have taken siddha medicine as their special study.  The 
siddhers were the eminent scientists in ancient times.  
The Siddhers belong to a school of great knowledge which 
originally consisted of Eighteen members known as Moolavarga 
Siddhers.  They were highly not only cultured, intellectual and spiritual 
faculties but also combined with supernatural powers.  They contain a 
large number of valuable formula and exhibit minute enumerations of 
morbid symptoms.  The Moolavarga Siddhers were popular in major 
fields, such as Alchemy, Medicine, yoga and Philosophy (thjk;/ 
itj;jpak;/ Nahfk;/ Qhdk;) 
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MEDICINE : 
In order to maintain immortality siddhers adopted many means to 
protect their health.  In such effort, they have followed three different 
process such as Alchemy, Yoga, and philosophical wisdom to keep their 
life safe and also to avoid aging.  During such practices, they could 
recognize many, medicinal products.  As and when they find illness in 
them and succeed in over coming their deficiency and failure in their 
health by using certain herbs, they started recording that in different form 
of songs and sutras.  Such records could have been used to public for 
application of those medicines as and when the Public approached those 
siddhers.  In due course of time such exchanges between siddhers and 
commons have taken the shape of Siddha Medicinal practices. In the 
Siddha System, Medicinal products are grouped in three different heads.  
 1. Raw material out of plant matters.  
 2. Raw material out of mineral matters. 
 3. Raw material out of animal matters.                                                             
RAW MATERIAL OUT OF PLANT MATTERS: 
 In Siddha system of medicine several herbs are used as medicine 
for various diseases.  Mostly single herbs are used to cure several 
diseases.  There are various herbal remedies, which have been used for 
thousands of years for the treatment of arthritis.  
 Keeping this in mind, the author has done this maximum effort in 
proving the therapeutic values of SANGAN VER PATTAI (root bark of 
Azima tetracantha Larn) a herb with a very old tradition and significance 
in the treatment of Azhal keel vayu to unfold the hidden to the medical 
world.  
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AIM AND OBJECTIVE 
 The aim of this dissertation is to establish that the drug SANGAN 
VER PATTAI CHOORANAM an effective remedy for the disease of 
Azhal keel vayu. It is one of the vadha diseases in Siddha system of 
medicine and can be compared to the Osteoarthritis in modern medicine. 
The disease is also termed as Degenerative joint disease of the human 
being, a leading cause of disability in the elderly. 
 The progressive prevalence of Azhal keel vayu is seen with 
increase in age. In a random survey, people affected  by Azhal keel vayu 
below 40 years of age is only 2% between the age of 40 to 60 years the 
prevalence is  30% and above the age of 60 years it is 68%. 
 In this study author selected SANGAN VER PATTAI 
CHOORANAM for the study of Azhal keel vayu.  
¾ The number of Azhal keel vayu patients attending 
Govt. Siddha Medical College Hospital is very much 
increasing 
¾ It is easily available and economically 
¾ It is easily identified 
¾ It has no adverse (or) side effect when it was given in 
long term treatment. 
¾ No Other person studied so far. 
In this dissertation the analysis of sangan ver pattai is done in all 
aspects like. 
¾ Botanical aspect 
¾ Chemical aspect 
¾ Gunapadam aspect 
¾ Bio-Chemical analysis 
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¾ Pharmacological analysis 
¾ Anti-microbial analysis 
¾ Clinical assessment 
¾ Bio-Statistical analysis 
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BOTANICAL ASPECT 
AZIMA TETRACANTHA 
SCIENTIFIC CLASSIFICATION: 
 Kingdom:  Plantae (Plants/Piante) 
 Subkingdom: Tracheobionta (Vascular plants/piante vascolari) 
 Superdivision: Spermatophyta (Seed plants/piante con semi) 
 Division: Magnoliophyta (Flowering plants/piante con fiori) 
 Class: Magnoliopsida (Dicotyledons/Dicotiledoni) 
 Subclass: Rosidae 
 Order: Celastrales 
 Family: Salvadoraceae 
 Genus: Azima Lam 
 Species: Azima tetracantha Lam 
     -Internet  
      Botanica sistematica – 2006 
      Luigi Rignanese 
BOTANICAL NAME: Azima Tetracantha 
CHROMOSOME NUMBER: 
2n = 22 
ORIGIN AND GEOGRAPHIC DISTRIBUTION:    
Azima tetracantha occurs naturally in Central, Eastern and 
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Southern Africa as well as in the Indian ocean islands and extends 
through Arabia to tropical Asia.  
DESCRIPTION:             
Dioecious, erect shrub upto 90 cm tall with [-1] 2 spines 0.5 -5cm 
long in each leaf axil, sometimes scandent with stems upto 8m long: 
Branchlets terete or quadrangular glabrous to densely hairy.  
LEAVES: Decussately opposite, simple and entire 
STIPULES: Absent or rudimentary 
PETIOLE: Short 
 Blade elliptical – oblong to ovate – oblong or orbicular, 1.5 – 
5.5cm x 0.5 – 4.5cm, base rounded or somewhat narrowed, apex 
mucronate, pinnately veined with one pair of lateral veins from near the 
base. 
INFLORESCENCE: An axillary, sometimes terminal spike or cyme 
upto 3cm long or flowers solitary. 
BRACTS: Ovate, often with long and spinous mucro. 
FLOWERS: Unisexual, regular, 4 merous, usually sessile. 
CALYX: Campanulate, 2-4mm long, with triangular lobes. 
PETALS: Linear – oblong to oblong, greenish to yellowish, the upper 
part reflexed over the calyx, 2-5mm long. 
MALE FLOWERS (♂):             
 Stamens inserted at the base of the rudimentary ovary, exserted  
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FEMALE FLOWERS (♀):  
Staminodes and superior ovary, upto 4.5mm long with a broad 
sessile stigma.          
FRUIT:            
A globose berry, 0.5 –1cm in diameter, 1-2 seeded, green turning 
white, with persistent stigma. 
SEEDS: Disk – like, brown to black. 
OTHER BOTANICAL INFORMATION: 
 Azima comprises about 4 species in mainland Africa, Madagascar 
and Asia and is characterized by long axillary spines. Over the range of 
its distribution Azima tetracantha varies considerably, yet it is an easily 
recognizable and distinct species. In southern Africa the male plants lack 
spines, or have poorly developed ones, while female specimens have long 
spines. 
GROWTH AND DEVELOPMENT: 
 The scandent, straggling growth habit and its spines make Azima 
tetracantha a useful species for hedges. The hedge tends to open up 
underneath but pruning will keep it in shape. It coppices readily and 
spreads through underground runners. 
ECOLOGY: 
 Azima tetracantha is found in bush, scrub and forest, along rivers 
and at the coast, upto 1100 m altitude. In East Africa it is common along 
banks of seasonal rivers where the soil is saline, notably in the edges of 
mangrove. In South Africa Azima tetracantha occurs on hill sides, in 
shrub savanna, often on termitaria, and at the coast. 
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PROPAGATION AND PLANTING:        
 A few specialist nurseries in the United States offer seeds of Azima 
tetracantha for sale for ornamental purposes. Multiplication through 
cuttings is possible. 
FLOWERING TIME: September – March 
ALTITUDE RANGE: Upto 1200m 
GENETIC RESOURCES: 
 Azima tetracantha is a common, widespread pioneer and thus there 
is no immediate risk of overharvesting for human use. 
PROSPECTS: 
 The use of Azima tetracantha appears to be limited and only 
occasional in Africa. As all parts contain glucosinolate 
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CHEMICAL ASPECT 
PHYTO CHEMISTRY 
ALL PLANT PARTS CONTAIN: 
 Dimeric piperidine alkaloids  -    Azimine 
- Azcarpine 
- Carpaine 
ROOTS AND LEAVES CONTAIN: 
 Terpenoids 
SEEDS CONTAIN: 
 25 flavonoids predominantly as  - Glycosides 
       - Acyl - Glycosides 
       - Quercetin 
       - Isorhamnetin 
       - Rhamnetin 
       - Rhamnazin 
ALL PARTS CONTAIN:  
Glucosinolates 
SEED AND ROOTS CONTAIN:  
N – methoxy -3- indolylmethly – glucosinolate 
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SEED OIL CONTAINS: 
 The fatty acids   -    Myristic acid 0.2% 
- Palmitic acid 5% 
- Stearic acid 15% 
- Arachidic acid 7% 
- Behenic acid 2% 
- Oleic acid 32% 
- Linoleic acid 18% 
- Eicosenoic acid 21% 
- Internet 
Protabase record 
- Medicinal plants record display 
ROOT CONTAIN: 
 Azimine 
 -kUj;Jtj; jhtutpay; gf;fk; - 117 
 By Dr. S. Soma Sundaram M.Sc., Ph.D., 
USES: 
¾ In East Africa the pounded roots of Azima tetracantha are 
applied directly to snake bites and an infusion is taken orally as 
a treatment for them, while in Zimbabwe a mixture of roots 
and leaves is used similarly. 
¾ The Bajun people of the Kenyan coast use a root decoction to 
treat stomach disorders. 
¾ In Madagascar an infusion of the leaves is used to treat 
venereal diseases. 
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¾ In the cape province of South Africa the juice of the berries is 
applied directly into the ear to treat earache and the dried root 
is ground, put in cold water and given to cows to facilitate 
difficult parturition. 
¾ The Zulu people of South Africa apply the sap of the plant 
directly to treat toothache and bleeding gums after tooth 
extraction and also as a disinfectant. 
¾ In India and Srilanka the root, root barks and leaves are added 
to food as a remedy for rheumatism. The plant is considered 
diuretic and is also used to treat dropsy, dyspepsia, chronic 
diarrhoea and as a stimulant tonic. 
¾ In Western India juice of the leaves is applied as eardrops 
against earache and crushed leaves are placed on painful teeth. 
¾ The fruit is edible, Azima tetracantha is browsed by livestock. 
It is planted as live fence in Bangalore (India). 
¾ In Malaysia pickled leaves are used as an appetizer and against 
colds. 
¾ The plant is promoted as an ornamental in the United states. 
- Internet Protabase record 
Medicinal plants record display. 
 The juice of the leaves is said to relieve the cough of phthisis and 
asthma. The bark is reputed to be an expectorant. 
- The wealth of India 
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GUNAPADAM ASPECT 
AZIMA TETRACANTHA -  rq;fQ;nrb> ew;rq;fd;>  
Kl;rq;fd;> rq;fd; 
VERNACULAR NAMES 
 Eng : Mistletee berry thorn, four spined meneita 
 Tel : Tella – Upi 
 Mal : Changan 
 Sans : Kundali 
 Hind : Kalangur - kamai 
gad;gLk; cWg;G :  ,iy> NtH> ghy; 
 Rit  : ifg;G 
 jd;ik : ntg;gk; 
gphpT  : fhHg;G 
nra;if: 
 rpWePHg;ngUf;fp  ( Diuretic) 
 ntg;gKz;lhf;fp (Stimulant) 
 JtHg;gp  (Astringent) 
 cukhf;fp  (Tonic) 
 Kiwntg;gfw;wp (Antiperiodic) 
 Nfhioafw;wp (Expectorant) 
  13
Fzk;: 
 ,jd; ,iyf;Fk; NtUf;Fk;> Nrhig> fug;ghd;> ntg;gk;> foiy> 
Fd;kk;> fPy;tPf;fk;> thjNfhgk;> gpj;jNeha;> gy eQ;Rfs; ,it ePq;Fk; 
fz; Jyf;fKk;> kpFjpAk; FUjpg; ngUf;Fk; cz;lhFk;. 
‘tPf;fk; fug;ghd; tpjhfk; fpue;jp Fd;kk; 
  Cf;fkpFQ; #iytha; NthLgpj;jj; - jhf;F tplk; 
  tPWNkh fz;Jyq;Fk; tPRgrp uj;jKz;lhk; 
  $W rq;fd; Nthpiy fl;F”. 
         (m.F) 
,jd; NtHg;gl;ilf;F> Nfhio> ,Uky;> IaRuk;> fLg;G> Ia 
mijg;G> fpue;jp> cl;Ruk;> tspNeha;fs;> tapw;Wg; GOf;fs; Mfpait 
NghFk;. 
  ‘rq;fd;NtHg; gl;il rspapUkiyr; Ruj;ij 
  mq;fth jf;fLg;ig Mlijg;igg; - gq;fNk 
  nra;Aq; fpue;jpiaAs; jPfhy; fpUkpiaapt; 
  itae; jdpnyhopf;F khy;”. 
         (m.F) 
 ,jd; NtHg;gl;ilg; ghYf;F> tPf;fk;> ePNuw;wk;> RuNtfk; Mfpait 
ePq;Fk;. 
  ‘rq;fd;ghy; tPf;fkijj; jhd;Nghf;Fk; ePHtbf;Fk; 
  mq;FuR ntg;gfw;Wk; Iakpy;iy” 
        (m.F) 
,iy 
t.F: ,iyapd; FbePiu tspNeha;fl;F toq;fp tuyhk;. ,iyia 
miuj;J mk;ikg; Gz;fSf;Fg; G+rf; FzkhFk;. ,ijf; fug;ghDf;Fk; 
G+ryhk;. 
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,jd; ,iyiaAk;> Ntg;gpiyiaAk; XH msthf vLj;jiuj;J> 
rpW Gd;idf;fhasT gpurtkhd ehs; Kjy; VO ehs; tiuapy; jpdk; 
,U Ntis nfhLj;Jg; gj;jpak; itf;f> gps;isg; ngw;w gpd; cz;lhFk; 
mOf;fpd; jiliag; Nghf;Fk;. 
 ,jd; ,iyr;rhW Nfhioia ntspg;gLj;Jk;;;> ,Ukiyj; 
jzpf;Fk;. 
rq;fd; 
  ‘rq;fjl; #uzQ; rhg;gpl ntUfb 
  aq;fTs; spuzK kue;ijA kWNk” 
        (Njud;-ntz;gh) 
(nghUs;) 
 rq;fd; gl;iliag; nghbj;J Kiwg;gb cl;nfhz;L te;jhy;> 
clypDs; cz;lhd> Gz;fSk; Vida Neha;fSk; mfYk;. 
NtHg;gl;il 
 NtHg;gl;ilia ,bj;Jg; gpope;j ghiy> xd;W my;yJ xd;wiug; 
gynkLj;J> mjw;fpUklq;F> nts;shl;Lg;ghy;> NrHj;Jf; nfhLj;Jtu 
rpWePiug; ngUf;fp ntspg;gLj;JtJld;> cly; tPf;fk;> Runtg;gk; 
,itfisAk; Nghf;Fk;. 
 NtHg;gl;ilia miuj;Jg; G+rptu> tPf;fq;fs; fiuAk;. 
 ,ijf; FbePhpl;Lf; nfhLj;Jtu> Kiwr;Ruk;> fPy;tPf;fk;> Nfhio> 
,Uky;> IaRuk;> cl;Ruk; jzpAk;. 
 - Fzghlk; Kjy; ghfk; (nghUl;gz;GE}y;) 
-itj;jpa ,uj;jpdk; f.r.KUNfr KjypahH 
(g.vz;.414) 
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rq;fd; NtH NrUk; thj Neha;f;fhd kUe;Jfs;> msT kw;Wk; jPUk; 
Neha;fs; 
1. rHthq;f thj #uzk; - rpfpr;rhuj;e jPgk; ,uz;lhk;  ghfk; -      
  rp.fz;Zrhkpg;gps;is (g.vz;. 164.) 
msT  : Ntisf;F jphpfbg; gpukhzk; jpdk; ,UNtis. 
jPUk;Neha;fs; : #iy> nfHg;gr;#iy> Fly;thjk;> thj#iy>  
  uj;jgpj;j #iy> rHthq;fthjk;. 
2. fhyUj;jpuhq;f vz;nza;     - rpfpr;rhuj;e jPgk; ,uz;lhk; ghfk;  
      rp.fz;Zrhkpg;gps;is (g.vz;.189) 
msT : Ntisf;F ½> ¼ gyk; tPjk; Njf jplj;jpw;F  
  Vw;wthW jpdk; xU Ntis nfhLj;Jtu     
  ehiye;J Kiw NgjpahFk;. ,g;gb 3>5 ehs;   
  nfhLf;fTk;. 
jPUk; Neha;fs; : kz;iltyp> Fj;jy;> Roy; thjk;> ,rpT thjk;>  
 mz;lthjk;> eLf;fy; thjk;> ,Lg;G ,rpT thjk;>  
 jpkpH thjk;> Klf;Fthjk;. 
3. Nkfhjp vz;nza;  - rpfpr;rh uj;e jPgk; ,uz;lhk; ghfk;   
  rp.fz;Zrhkpg;gps;is (g.vz;.192) 
msT : Ntisf;F cr;rpf;fuz;b tPjk; jpdk; ,UNtis rhg;gplTk;. 
jPUk; Neha;fs;:  
iffhy; Klf;F> jbg;G> F\;lk;> tpuzk;> kJNkfk;> nrhwp> rpuq;F> 
gil> Njky;> gTj;jpuk;> Gw;Wfs;> fpue;jp> miuahg;G> fz;lkhiy> 
fw;whio ehw;wk;> kyL Kjypa gy Nuhfq;fSk; jPUk;.  
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4. ,urfe;jp nkOF   - rpfpr;rh uj;e jPgk; ,uz;lhk; ghfk;  
 - rp.fz;Zrhkpg;gps;is. (g.vz;.255) 
msT:  Ntisf;Fj; Njw;whq; nfhl;ilg; gpukhzk; jpdk;  
,UNtis 20 ehl;fs; rhg;gplTk;. 
jPUk; Neha;fs;:  
F\;lk;> jpkpH> fz;lkhiy> Nkf#iy> fpue;jp> miuahg;G> Gw;W> 
fUk;Gs;sp> Nkf Cwy;> glH jhkiu> gTj;jpuk;> Foptpuzk;> 
njhilthio. 
5. thiy ur nkOF:        - rpfpr;rh uj;e jPgk; ,uz;lhk; ghfk;   
     - rp.fz;Zrhkpg;gps;is. (g.vz;.257) 
msT:  
Ntisf;F Fd;wp msT gidnty;yj;jpy; itj;J jpdk; 2 
nghOJ nfhLf;fTk.; ,g;gb xUKiw 7-ehs; nfhLf;fTk;.  
jPUk; Neha;fs;: 
 Nkfk;> gpbg;G> jbg;G> Filr;ry;> Fj;jy;> Fl;lk;> je;jp nts;is> 
Mwhj uzk;> gil> nrhwprpuq;F> Gw;W> gpsit> GOntl;L> fUNkfk;> 
ntz;Fl;lk;> fpue;jp> GiuFoy;> Njfk; vy;yhk; cz;lhd kWf;fy; 
vy;yhk; jPUk;. 
6. fjypfe;j urhadk; - NghfH 700 (g.vz;. 17) 
msT: nfhl;ilg;ghf;fsT 
jPUk; Neha;fs;:  
ngUk;ghL> vYk;GUf;fp> gpuNkfq;fs;> Nkftif> 18 #iy> fpue;jp> 
Fl;lk;> miuahg;G> m];jpRuk;> mj;jpntl;il> c\;zk;> vhpT> fhe;jy;> 
rpuq;F> nrhwp> fug;ghd;> Cwy;> fpuhzptif> %yr;#L> ,isg;gpUky;> 
fhrk;> ePhpopT> fphpr;rpdq;fs;> #rpfhnfHg;gk; - 7 tif Nuhfq;fs;. 
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7. fdkz;^u nre;J}uk; -    mDNghf tapj;jpa gpuk;kufrpak; -ghfk;1.  
    jpU. KDrhkp Kjypahh; (g.vz;. 47) 
msT: mhprp vil Njdpy; nfhLf;fTk;. 
jPUk; Neha;fs;:  
Rthrfhrk;> cg;Grk;> \ak;> fpuhzp> mjprhuk; cs;fha;r;ry;>  
Nrhif> tPf;fk;> vl;Ltpj ghz;L ,itfs; jPUk;. fLk;gj;jpak;. 
8. fug;ghDf;F vz;nza;: 
     mDNghf tapj;jpak; gpuk;kufrpak; ghfk; 2      
     jpU. KDrhkp KjypahH (g.vz;. 60) 
msT  :  rpW fuz;b tPjk; 3-5 ehs; nfhLf;fTk;. 
jPUk; Neha;fs; 
fug;ghd; 
9. rfy Nkfuh[hq;f urnfe;jp nkOF:  
mDNghf tapj;jpak; gpuk;k ufrpak; - ghfk; 
3 jpU.KDrhkp KjypahH (g.vz;.33) 
msT  : Rz;ilf;fha; msT 1 kz;lyk; cl;nfhs;sTk;. 
jPUk; Neha;fs; 
ntb#iy> Nkf#iy> ,b#iy> Gilf;Fk; #iy> thj#iy> 
fhy;Filr;ry;> muiz> tpg;GUjp> fz;lkhiy> Fl;lk;>  
10. rfy typg;Gfl;Fk; Nrhjphp\j;ijyk; : 
mDNghf tapj;jpak; gpuk;k ufrpak; ghfk; 4 
jpU.KDrhkp KjypahH (g.vz;.38) 
msT:  1 Jsp Kjy; 1 fhnril tiuapy; nfhLf;fTk;. jiy Kjy; 
Njfk; KOtJk; Nja;j;J JthiyaplTk;. NjftypT> 
tpahjpfspd; Nehf;fk; ,itAzHe;J cs;Sf;Ff; 
nfhLg;gJk; rHthq;f Jthiy ,LtJk; gz;bjHfSila 
gf;Ftkhk;. 
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jPUk; tpahjpfs;: 
 Nfhiz typg;G> Fkufz;l typg;G> gpw typg;G> fhf;if typg;G> 
[d;dptypg;G> uztypg;G> Kfthj typg;G> Kf[d;dp typg;G> Kay;thjk;> 
ghhprthjk;> cr;rpthjk;> fZthjk;> thjk; vd;W nrhy;yg;gl;l rfy 
thjq;fSk;> typg;G vd;W nrhy;yg;gl;l rfy typg;GfSk;> [d;dp vd;W 
nrhy;yg;gl;l rfy [d;dpfSk; jPUk;. 
gj;jpak;: 
 Gifapiy> Gsp> fUthL> kPd;> ,iwr;rp> fug;ghd; gz;lk;> yhfphp> 
nghb> Nghfk; ,it ePf;fTk;. 
 11. rHtNuhfj;jpw;Fk; nghJ vz;nza;: 
    mDNghf tapj;jpak; gpuk;k ufrpak; ghfk; 5  
    jpU. KDrhkp Kjypahh; (g.vz;.53) 
msT  : fhiyapy; cr;rpf;fuz;b tPjk; nfhLf;fTk;. 
jPUk; Neha;fs;: 
 fzk;> khe;jk;> nrhhp rpuq;F> Gz;fs;> tha;Tfs;> ePHNkfk;> 
gpuNkfk; ahTk; jPUk;. 
12. rq;fd; NtHj;ijyk;:      
mDNghf tapj;jpak; gpuk;k ufrpak; ghfk; 6 
jpU. KDrhkp KjypahhH (g.vz;.61) 
jPUk; Neha;fs;: 
4 ehl;fSf;F 1 Kiw KOfptu Fl;lk;> nrhhp rpuq;F> fpue;jp> 
#iyNuhfk;> nrq;fug;ghd;> tz;Lfb> rpy;tp\q;fs;> ~ak;> Fj;jpUky;> 
thj~ak; NghFk;. 
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13. khe;jk;> tPf;fk;> tp\tPf;fk;> Ruk; 
ePHf;fl;Lf;Ff; fpahok;: 
mDNghf tapj;jpak; gpuk;k ufrpak; - ghfk; 
7 jpU.KDrhkp Kjypahh; (g.vz;.74) 
msT : fpahoj;ij Ntisf;F 1 gq;F tPjk; fhiy> khiyahf 3 ehs;  
  nfhLf;fTk;. 
jPUk; Neha;fs; 
rfy tPf;fk;> Ruk;> tapW cg;Grk; ahTk; jPUk;. 
14. mUzhry Nyfpak;: 
mDNghf tapj;jpak; gpuk;k ufrpak; - ghfk; 
8 jpU.KDrhkp KjypahH (g.vz;.46) 
msT: ghf;fsT> jpdk; 2 Ntis rhg;gplTk;. 
jPUk; Neha;fs; 
NkfthA> Nkf#iy> Nkf Cwy;> Nkfj;jbg;G> Nkf fhq;if 
Kjypa rfy NkfNuhfq;fSk; jPUk;. 
15. rptdhH Ntk;Gr; #uzk; - rpj;j itj;jpaj; jpul;L    (g.vz;.216) 
     - lh.f.eh. Fg;Grhkp KjypahH> H.P.I.M 
     - lh.f.R. cj;jkuhad;> H.P.I.M 
msT: fhiy> khiy ntUfbj;J}s; rptd;Ntk;Gj; japyk; fhR vil  
 NrHj;Jf; nfhLf;fTk;. 
jPUk; Neha;fs; 
#iy 18> Fl;lk;> FiwNeha; 
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16. rugq;f tpy;thjp ,Nyfpak;: - rpj;j itj;jpaj; jpul;L (g.vz;.241) 
     - lh.f.eh. Fg;Grhkp KjypahH> H.P.I.M 
     - lh.f.R. cj;jkuhad;> H.P.I.M      
msT: 1¼ tuhfndil msthf 1 ehisf;F ,UNtis  
 cl;nfhs;sTk; 1 kz;lyk;. 
jPUk; Neha;fs;:  
gpj;jntl;il> mWtif gpj;jg; ghz;L> vz;tif ~ak;> 
vz;tiff; Fd;kk;> mWtiff; fpuhzp> tha;f;frg;G> nts;Nshf;fhsk;> 
tha;ePH Cwy;> mf;fpdpke;jk;> #iy> iffhy; fhe;jy;> gpj;jk; 40. 
17. tspntg;Gf; (thjRuf;) FbePH: -  
rpj;j itj;jpaj; jpul;L    (g.vz;.293) 
     - lh.f.eh. Fg;Grhkp KjypahH> H.P.I.M 
     - lh.f.R. cj;jkuhad;> H.P.I.M 
msT: ¼ NrH. 
 thj uhl;r~f;Fspif gzvil nghbj;J> Njd; foQ;R NrHj;J 
,ioj;J Nkw;gbf; fpahoj;Jld; ,UNeuk; cl;nfhs;sTk;. 
jPUk; Neha;fs; 
thj Ruk;> eLf;F thjk;. 
18. kz;^uhjp milf;FbePH:    - rpj;j itj;jpaj; jpul;L    (g.vz;.295) 
     - lh.f.eh. Fg;Grhkp KjypahH> H.P.I.M 
     - lh.f.R. cj;jkuhad;> H.P.I.M   
msT: ¼ Mohf;F tPjk; ehs; xd;Wf;F ,uz;L (m) %d;W Ntisahff; 
nfhLf;fTk;. 
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jPUk; Neha;fs; 
ghz;L> Nrhif> fhkhiy> gytifg;gl;l kNfhjuq;fs; jPUk;. 
19. Ropkhe;jj;jpw;F vz;nza;: 
mDNghf tapj;jpak; gpuk;k ufrpak; ghfk; 1 
jpU. KDrhkp KjypahH. (g.vz;.63) 
msT: fhiyapy; 1 fuz;b tPjk; cs;Sf;Ff; nfhLf;fTk;. 
jPUk; Neha;fs; 
Ropkhe;jk;> nghiw khe;jk;> thjkhe;jk; 
20. Foe;ijfSf;Fk; nghpatHfSf;Fk; ml;ruk;> Nkfntl;il> fzk; 
,Jfl;F Fspj;jp vz;nza;:  
mDNghf tapj;jpak; gpuk;k ufrpak; ghfk; 2 
jpU. KDrhkp KjypahH (g.vz;.61) 
msT: Foe;ijfSf;F fuz;b tPjKk; nghpatHfSf;Ff; fhy;gyk;  
 tPjKk; 8 ehl;fs; nfhLf;fTk;. 
jPUk; Neha;fs;: ml;ruk;> Nkfntl;il> fzk;. 
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MATERIALS AND METHODS 
 In this dissertation Sangan Ver Pattai Chooranam (Powder) was 
taken for a single drug study.  The drug selected for this study was 
adopted according to the reference from the Porulpanbu Nool Mooligai 
Vaguppu By Murugesa Muthaliar.  
COLLECTION OF THE DRUG: 
 The study of raw drug Sangan Ver Pattai was collected around 
the Panakudi Taluk, at Tirunelveli District during the month of 
September.  
PURIFICATION OF THE RAW DRUG:  
 After collection, it was cleaned thoroughly and washed well with 
fresh  water. Then it was cut into pieces of 2 to 3 inches and allowed to 
dry completely under the sun shadow for about one to 2 weeks. 
PREPARATION OF THE DRUG: 
 The cleaned and dried Sangan Ver Pattai was made into a fine 
powder (Chooranam) and filtered by white cloth (Vasthirakayam). The 
powder (Chooranam) was pale wood colour has no perceptible odour.  
PURIFICATION OF THE CHOORANAM: 
 The Sangan Ver Pattai Chooranam was taken in a basin and 
mixed with Cow’s milk like a preparation of puttu (steam boiled food).  
In a pot half portion of it was filled with cow’s milk.  The mouth of the 
pot was covered with white cotton cloth.  The Moistured chooranam was 
placed on it.  Then the content was boiled till the Chooranam was fully 
cooked, then it was taken out and dried in sun shadow.  
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ROUTE OF ADMINISTRATION:  
 Enteral  route.  
DOSE: 
 One gram of SANGAN VER PATTAI CHOORANAM along 
with water twice a day before food. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  24
BIO – CHEMICAL ANALYSIS OF  
SANGAN VER PATTAI CHOORANAM 
PREPARATION OF THE EXTRACT:  5gms of Chooranam was 
weighed accurately and placed in a 250ml clean beaker. Then 50ml 
distilled water was added and dissolved well.  Then it was boiled well for 
about 10 minutes.  It is cooled and filtered in a 100ml volumetric flask 
and then it is made up to 100ml with distilled water.  This fluid was taken 
for analysis. 
TABLE : 1.1 QUALITATIVE ANALYSIS OF SANGAN VER 
PATTAI CHOORANAM 
S.No EXPERIMENT OBSERVATION INFERENCE 
1. Test for Calcium : 2ml of 
the above prepared extract is 
taken in a clean test tube. 2ml 
of 4% Ammonium oxalate 
solution is added to it.  
A white 
 precipitate is 
 formed  
 
Indicates the 
 presence of 
 calcium. 
  
2. Test for Sulphate: 2ml of the 
extract is added to 5% barium 
chloride solution 
A white 
 precipitate is 
 formed  
Indicates the 
 presence of 
 sulphate 
3. Test for Chloride : The 
extract is treated with silver 
nitrate solution 
A white precipitate 
is formed  
Indicates the 
presence of 
Chloride.  
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4. Test for Carbonate : The 
substance is treated with 
concentrated HCL. 
No brisk 
 effervessence is 
 formed   
 
Absence of 
 Carbonate.  
5. Test for Starch : The extract 
is added with weak iodine 
solution   
Blue colour is 
 formed   
Indicates the 
 presence of 
 Starch.  
6. Test for Iron – Ferric : The 
extract is treated with 
concentrated Glacial acetic 
acid and potassium ferro 
cyanide. 
No Blue colour is 
formed  
Absence of 
 ferric Iron.   
7. Test of Iron Ferrous:  The 
extract is treated with 
concentrated Nitric acid and 
ammonium thio cyanate.   
Blood red colour is 
formed  
Indicates the 
presence of 
ferrous Iron.  
8 Test for Phosphate: The 
extract is treated with 
ammonium Molybdate and 
concentrated nitric acid.  
No yellow 
precipitate is 
formed  
Absence of 
Phosphate.  
9. Test for Albumin : The 
extract is treated with 
Esbach’s reagent.  
No Yellow 
 precipitate is 
 formed  
Absence of 
Albumin. 
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10. Test for Tannic Acid: The 
extract is treated with ferric 
chloride. 
No blue black 
precipitate is 
formed 
Absence of 
Tannic Acid.  
11. Test for Unsaturation : 
Potassium permanganate 
solution is added to the 
extract.  
It gets decolourised  Indicates the 
 presence of 
 unsaturated 
compound.   
12. Test for the Reducing 
Sugar:  5ml of Benedict’s 
qualitative solution is taken in 
a test tube and allowed to boil 
for 2 mts and added 8-10 
drops of the extract and again 
boil it for 2 mts.  
No Colour change 
occurs.  
Absence of 
Reducing Sugar. 
13. Test for Amino Acid :  One 
or two drops of the extract is 
placed on a filter paper and 
dried it well.  After drying 
1% Ninhydrin is sprayed over 
the same and dried it well.  
 violet colour is 
formed  
Indicates the 
presence of 
Amino acid .  
 
Inference: 
 The given sample of sangan verpattai Chooranam contains 
calcium, sulphate, chloride, starch, ferrous iron, unsaturated 
compound and amino acid.       
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PHARMACOLOGICAL ANALYSIS 
ANTIPYRETIC STUDY OF SANGAN VER PATTAI 
CHOORANAM IN YEAST INDUCED HYPER PYREXIA ALBINO 
RATS 
 The test drug sangan ver pattai chooranam was screened for its 
antipyretic activity with the help of yeast induced hyperpyrexia albino 
rats. 
AIM 
 To evaluate antipyretic activity of sangan ver pattai chooranam.   
PREPARATION OF THE TEST DURG 
 1gm of sangan ver pattai chooranam was dissolved in 10ml of 
water.  1ml of this preparation contains 100mg of the test drug. 
YEAST INDUCED HYPERPYREXIA 
 Six healthy albino rats of either sex, weighing between 80-100gm 
were selected.  They were divided into 3 groups of 2 rats in each group.  
All the rats were made hyperthermic by giving subcutaneous injection of 
12% of yeast in distilled water 1ml/100gm of body weight. 
 After 10 hours, the initial temperature (0 hr) was taken for all the 
rats.  First group of rats were given 2ml of water and kept as control.  The 
second group received 20mg/100gm of body weight of Paracetamol and 
the third one received the test drug sangan ver pattai chooranam 
100mg/100gm body weight. 
 The mean rectal temperatures for all the rats were recorded at 1½ 
hr, 3hrs, and 4 ½ hours after the drug administration. 
 The difference between the 3 groups are measured and compared. 
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RESULTS 
The details of the experiment and the results were shown in the 
table. 
TABEL : 1.2 ANTIPYRETIC EFFECT OF SANGAN VER PATTAI 
CHOORANAM  
S. 
No. 
Name of Drug 
/ Groups 
Dose / 
100 
gm 
body 
weight
Initial 
Temperature 
in centigrade 
After Drug 
Administration 
Remarks 
1 ½ 
hour
3.0 
hour
4 ½ 
hour 
1. 
 
Control 
(Water) 
2ml 
36.0 
37.0 
36.0 
38.0 
36.0 
38.0 
37.0 
39.0 
38.0 - 
2. 
Standard 
(Paracetamol) 
20mg  
37.0 
38.0 
36.5 
37.5 
36.0 
36.0 
35.0 
35.0 
35.0 - 
3. 
Sangan Ver 
Pattai 
Chooranam 
100mg 
38.0 
38.0 
37.5 
37.5 
36.0 
37.0 
35.5 
36.5 
36.0 - 
 
INFERENCE 
The test drug SANGAN VER PATTAI CHOORANAM has got 
significant Anti Pyretic activity.  
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STUDY OF ANALGESIC EFFECT OF 
SANGAN VER  PATTAI CHOORANAM - ON  
ALBINO RATS BY TAIL – FLICK METHOD. 
AIM: 
 To study the analgesic effect of Sangan Ver Pattai Chooranam on 
albino rats by Tail-flick method. 
MATERIALS AND METHODS: 
PREPARATION OF THE TEST DRUG (SANGAN VER PATTAI 
CHOORANAM): 
 1 gram of Sangan Ver Pattai Chooranam was suspended in 10ml of 
distilled water using as suspending agent. This 1ml contains 100mg of the 
test  drug (Sangan Ver pattai Chooranam). 
INSTRUMENT: 
 Hot water bath maintained at 550c±0.50c was used as the source of 
stimulus. 
PROCEDURE: 
 Six healthy albino rats weighing 100-200gms of both sexes were 
selected. The tail of each rat was dipped in the hot water bath and time 
taken for the rat to remove the tail from the water bath was noted. The 
rats that take more than 5 seconds to remove the tail were excluded from 
the equipment. Then the rats were divided into 3 equal groups, each 
group containing 2 rats. 
 The first group was kept as control by giving distilled water of 
2ml/100 grams of body weight. The second group was given paracetamol 
10mg/100 grams of body weight and kept as standard. The third group 
  30
was given the test drug Sangan Ver Pattai Chooranam 100mg/100 grams 
of body weight. ½ hr, 1 hr and 1½ hrs after drug administration the rats 
were again tested by dipping the tail in hot water bath. The time taken for 
the rat to remove the tail was noted as done initially. 
 The result of control group, standard group and tested drug group 
were tabulated and compared.  
TABLE : 1.3 STUDY OF ANALGESIC EFFECT OF USING THE 
DRUG OF SANGAN VER PATTAI CHOORANAM 
S.No. 
Name of 
Drugs / 
Groups 
Dose / 
100 
gram 
body 
weight 
Initial 
Reading
After Drug Administration 
Mean 
Difference
½ hr. 
Average
1 hr. 
Average
1 ½ hr. 
Average 
1. 
Control 
(water) 
2ml 2.5secs 2.5secs 2.5secs 2.5secs 2.5secs 
2 
Standard 
Paracetamol 
10mg 3.0secs 4.0secs 5.0secs 6.5secs 6.5secs 
3. 
Test Drug 
Sangan ver 
Pattai 
Chooranam 
100mg 2.5secs 3.5secs 4.5secs 6.0secs 6.0secs 
INFERENCE: 
 The test drug Sangan Ver Pattai Chooranam has got the 
significant analgesic action. 
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ANTI-INFLAMMATORY STUDY 
STUDY OF ACUTE ANTI-INFLAMMATORY 
CARRAGEENIN INDUCED HIND PAW OEDEMA METHOD. 
METHOD: 
 Carrageenin induced hind paw oedema method in Albino rats. 
AIM: 
 To study the acute anti-inflammatory effect of Sangan Ver Pattai 
Chooranam by carrageenin induced hind paw oedema method in albino 
rats. 
DRUG PREPARATION: 
 1 gram of Sangan Ver Pattai Chooranam was suspended in 10ml of 
distilled water using as suspending agent. This 1ml contains 100mg of the 
test drug (Sangan Ver Pattai Chooranam). 
PROCEDURE: 
 Six healthy albino rats weighing between 100-120 grams of both 
sexes were selected. The volume of each hind paw was measured by 
using the mercury plethysmograph. 
 After the measurement of hind paw of all the rats, they were 
divided into three groups, each group containing two rats. 
 The first group was kept as control by giving distilled water of 
2ml/100 grams of body weight. The second group was given Ibu-profen 
20mg/100 grams of body weight and kept as standard. The third group 
was given test drug Sangan Ver Pattai Chooranam 100mg/100 grams of 
body weight. 
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 The drugs were administered orally, one hour after drug 
administration o.1ml 1% (w/v) of carrageenin suspension in water was 
injected in the planter surface of hind paw of rats. 
 All the animals were given carrageenin injection subcutaneously. 
Three hours after carrageenin injection, the hind paw volume was 
measured from the differences in the initial and final hind paw volume, 
the degree of the inflammation was calculated by taking the volume in the 
untreated control group as 100%.  
 The percentage of inflammation of the other group was calculated 
from the degree of anti-inflammatory effect of the treated and the tested 
groups were calculated.  
RESULTS : 
 The details of the experiment results are shown in the table.  
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TABLE : 1.4 STUDY OF ACUTE ANTI INFLAMMATORY 
EFFECT OF 
SANGAN VER PATTAI CHOORANAM 
BY HIND PAW METHOD 
 
Group Drug 
Dose/100gm 
of body 
weight 
Initial 
Reading 
Average
Finial 
Reading 
Average
Mean 
Difference
Percentage 
inflammation 
Percentage 
inhibition 
Control 
 
Standard 
 
Test 
drug 
Water 
 
Ibuprofen 
 
Sangan 
ver Pattai 
chooranam 
2ml 
 
20mg 
 
100mg 
 
1.1 
 
1.3 
 
1.0 
1.85 
 
1.35 
 
1.2 
0.75 
 
0.05 
 
0.2 
100 
 
6.6 
 
26.6 
- 
 
93.4 
 
73.42 
 
INFERENCE  
The test drug Sangan Ver Pattai Chooranam has got  the 
significant acute anti inflammatory action. 
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ANTI-MICROBIAL (BACTERIAL) ACTIVITY OF 
SANGAN VER PATTAI CHOORANAM 
AIM: 
To identify the anti-microbial (Bacterial) activity of Sangan Ver 
Pattai Chooranam against Streptococcus, Staphylococcus, proteus, 
Pseudomonas, E.coli and Klebsiella. 
METHOD :  Kirby Bauer Disc Diffusion Method 
MEDIUM : Mueller Hinton agar 
COMPONENTS OF MEDIUM: 
• Beef extract   : 300gms /lit 
• Agar    : 17gms /lit 
• Starch   : 1.50gms /lit 
• Casein Hydroxylate : 17.50gms /lit 
• Distilled Water  : 1000 ml 
• pH     : 7.6 
PROCEDURE: 
 The media was prepared from the above components and poured 
and dried on a Petri dish.  The organism was streaked on the medium and 
the test drug (1 gm drug in 10 ml of Water) was placed on the medium. 
This is incubated at 370C for one over night and observed for the 
susceptibility shown up clearance around the drug.  
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TABLE : 1.5 ANTI-MICROBIAL SUSCEPTIBILITY TEST 
REPORT 
No. Organism Susceptibility 
1. Staphylococcus Resistant 
2. Pseudomonas Resistant 
3. E. coli Resistant 
4. Klebsiella Resistant 
5. Proteus Resistant 
6. Streptococcus Resistant 
 
RESULT: 
  The test drug SANGAN VER PATTAI CHOORANAM was 
Resistant For All The Organisms. 
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CLINICAL ASSESSMENT OF SANGAN VER PATTAI 
CHOORANAM 
 Azhal Keel vaya (Osteoarthritis) is the common complaint in our 
clinical practice. It is a degenerative arthritis.  In order to assess efficacy 
of Sangan Ver Pattai Chooranam for Azhal Kerl Vayu cases, it was tried 
clinically both in Out-patient and In-patient cases of both sexes. 
 For all the cases, full clinical data was recorded and they were 
diagnosed on the basis of Siddha Principles (Mukkuttram, envagai 
thervu) and Modern Clinical Parameters.  They were different severity of 
signs and Symptoms like pain, swelling, difficulty by moving the affected 
joints.  
 Clinically the patients were selected as Azhal Keel vayu according 
to the following including and excluding criterias. 
CRITERIA SELECTED FOR STUDY:  
CRITERIA FOR INCLUSION: 
 Age:  In between 40 to 60 years. 
 Pain and swelling of the weight bearing joints.  
 Difficulty by moving the affected joints. 
 Morning stiffness. 
 Crepitations of the joints.  
 Effusion of the joints.  
CRITERIA FOR EXCLUSION: 
 Age – Younger age group. 
 History of smaller joints involvement followed by major 
joints. 
 Redness, tenderness, warmth of the swelling. 
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 Complaints of shifting in nature.  
 Other types of arthritis such as Gonococcal, Syphilitic, 
Gouty, psoriatic arthritis and T.B. Arthritis 
 Confirmation of diagnosis can be carried out with the Radiological  
findings of the affected joints such as narrowed joint space, osteophytes, 
subchondral bone sclerosis. 
 Forty patients were selected for the study from both sexes. Of these 
thirty patients were studied as Out-patients and ten patients as In–
patients.  
The Biochemical and pathological investigations are done as  
BLOOD: 
¾ Total count 
¾ Differential count 
¾ Erythrocyte Sedimentation Rate 
¾ Haemoglobin content 
¾ Blood Sugar 
¾ Blood Urea 
¾ Serum Cholesterol 
URINE: 
¾ Albumin 
¾ Sugar   
¾ Deposit 
 Radiological studies of the affected joints were also carried out in 
the Govt. Siddha Medical College Hospital at Palayamkottai.  
 The measurement of the swollen part and the time taken for a travel 
of 100 feet length was recorded before and after the treatment. 
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 The cases were screened as per the above criteria’s and selected 
from the Out-patient and In-patient Govt. Siddha Medical College, 
Palayamkottai.  
DRUG AND DOSAGE: 
 The drug Sangan Ver Pattai Chooranam was administered orally 
in a dose of 1 gm twice a day with water before food for 4 to 5 weeks 
according to the severity of the symptoms.  
DIETERIC RESTRICTION AND MEDICAL ADVICE : 
¾ Diet which Contains easily digestible food is advised.  
¾ Advised to avoid those foods which increase the Vayu 
kuttram like Ripe Banana, Potato, Dholl, Curd.  
¾ In take of hot water and hot foods. 
¾ Cool Substances were to be avoided 
¾ Advised to avoid Chill weather.  
¾ Obese individuals advised to reduce the body weight. 
OBSERVATION: 
 The result was observed on the basis of the symptomatic relief 
obtained by the patients.  Out of 40 cases 16 were males and the 
remaining 24 were females.  Most of the cases belonged to the age group 
between 40 to 60 years and most of the patients were having the evidence 
of family history.  
RESULT: 
 Out of the 40 cases administered with Sangan Ver Pattai 
Chooranam 33 cases (82.5%) showed complete relief from pain.  
Swelling and restricted movements of 5 cases (12.5%) showed partial 
relief and 2 cases (5 %) poor response.  The patients were treated upto 21 
to 45 days according to the severity of the signs and symptoms. 
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BIO-STATISTICAL ANALYSIS 
STUDY ON THE EFFECTIENESS OF SANGAN VER PATTAI 
CHOORANAM INCURRING OF  AZHAL KEEL VAYU 
Description of Clinical trials:  
The clinical trials which were given Sangan ver Pattai Chooranam 
were analysed and described according to their sex and age.  
TABLE – 1.6 AGE AND SEX WISE DISTRIBUTION OF STUDY 
SUBSIDES 
S.No. Age group 
Male Female Total 
N 
II
o
 % N 
II
o
 % N 
II
o
 % 
1 40-44 0 0 2 8.3 2 5.0 
2 45-49 7 43.7 4 16.7 11 27.5 
3 50-54 0 18.8 4 16.7 7 17.5 
4 55-59 2 12.5 6 25.0 8 20.0 
5 60-64 4 25.0 8 33.3 12 30 
 Total 16 100.0 24 100.0 40 100.0 
 Mean 51.9 53.7 53.0 
 Std. Deviation 6.5 6.6 6.57 
 ‘t’ value 0.854   
 
Significance P>0.05  
Population mean value @ 95% 
C.I. 51 to 55 years 
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The above table – 1.6 describes the age and sex of the study 
subjects.   The males participation  was 40% and the female was 60% in 
respect of age, the mean age of female was 51.9 ±  6.5 and female mean 
age was 53.7 ±  6.6.  The sexwise mean ages were not statistically 
significent (t=0.854, d.f=38 and P>0.05).  The total study subjects was 
53.0 ±  6.57 and the estimated population mean at 95% confidence 
interval was between 51 to 55 years.  
Effectiveness the drug: 
 The effectiveness of the drug was analyzed and interpreted by 
calculating mean and standard deviation of the variables life pain, 
stiffness, measurement, tenderness, swelling and duration of 100 feet 
walk.  The above variables were recorded before administration of the 
drug and after administration of the drug.  The mean and S.D of the all 
variables were calculated for both time (before and after) and compared.    
The results are available the below table.  
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TABLE : 1.7  STANDARD DEVIATION OF THE VARIABLES 
SYMPTOMS 
S. No. Variable Signs n
II
o
 Leg 
Before After 
‘t’ Significance 
Mean S.D Mean S.D 
1 Pain 40 
Right 1.95 0.5 1.0 0.22 11.925 P < 0.0001 
Left 1.95 0.71 1.0 0.32 10.064 P < 0.0001 
2 Stiffness 40 
Right 0.85 0.36 0.025 0.16 13.559 P < 0.0001 
Left 0.85 0.43 0.025 0.16 13.559 P < 0.0001 
3 Measurement 40 
Right 39.4 4.48 36.2 3.86 11.342 P < 0.0001 
Left 39.15 4.47 36.5 4.29 8.459 P < 0.0001 
4 Tenderness 40 
Right 0.875 0.33 0.025 0.16 14.866 P < 0.0001 
Left 0.80 0.41 0.10 0.30 9.529 P < 0.0001 
5 Swelling 40 
Right 1.025 0.58 0.15 0.48 10.734 P < 0.0001 
Left 0.95 0.6 0.23 0.53 7.66 P < 0.0001 
6 
100 feet 
Walking time 
(sec) 
40  38.975 4.123 33.6 3.75 15.427 P < 0.0001 
 
 The above table – 1.7 shows that the comparison of symptoms 
before and after administration of the drug.  The pain in both legs before 
treatment was 1.95 ± 0.5 and 1.95 ± 0.71 and the same in the after 
treatment was 1.0 ± 0.22 and 1 ± 0.32.  The differences of the pain before 
and after in the both legs was 0.95, and the differences was statistically 
highly significant ( t= 11.925, d.f = 39 and P < 0.001).  The stiffness on 
the right leg was 0.85 ± 0.36 and 0.025 ± 0.16 before and after 
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respectively.  In left leg the stiffness before and after was 0.85 ± 0.43 and 
0.025 ± 0.16 respectively. The reduction of pain was 0.825.  The main 
reduction of stiffness in both legs was statically highly significant (t= 
13.559, d.f = 39 and P < 0.0001).  The mean measurement in the right leg 
before treatment was 39.4 ± 4.48 and after treatment was 36.2 ± 3.86.  
The reduction of measurement 3.2c.m. was statistically significant 
(t=11.242, d.f. = 39 and P < 0.001).  Similarly, the measurement in the 
left leg was also reduced as 2.6 c.m.  This mean reduction of 
measurement was also statistically significant (t = 8.459 d.f = 29 and P < 
0.001). The mean reduction of tenderness in the right and left legs were 
0.85 and 0.7 respectively.  The deferential statistics were right leg ( t = 
14.866, d.f = 29 and P < 0.0001) and left leg ( t = 9.539 d.f = 29 and P < 
0.0001).  The Swelling of both legs were considerably reduced in the 
right leg of 0.875 (t = 10.729, d.f = 29 and P < 0.0001) and left leg as 
0.72 (t = 7.66, d.f = 29 and P < 0.0001).  The mean 100 feat waking 
distance before treatment was 38.975 ± 4.123 seconds and the same was 
reduced to 33.6 ± 3.75.  The mean reduction of 5.375 seconds was 
statistically highly significant (‘t’ = 15.427, d.f = 29 and P < 0.0001).  
The considerable and statistically highly significant reduction of pain, 
stiffness measurement, tenderness, swelling and 100 feat waking time 
before were proving the effectiveness of Sangan Ver Pattai  Chooranam. 
Response of the drug: 
 The response of the drug was studied by prognosis as good, fair 
and poor.  The percentage of above 3 categories were given in the below 
table 1.8.  
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TABLE : 1.8 PERCENTAGE DISTRIBUTION OF  THE DRUG 
SANGAN VET PATTAI CHOORANAM. 
S.No. Prognosis 
Study Subject 
No 
II
o  % 
1 Good 33 82.5% 
2 Fair 5 12.5% 
3 Poor 2 5.0 
4 Total 40 100.0 
 ILLUSTRATING THE PROGNOSIS 
  The above table – 1.8 shows that the prognosis analysis of the 
patients response to the drug.  The prognosis analytical statistics had 
showed good response on 82% of the elements of the drug.  The 12.5% 
and 5% had shown fair and poor response respectively.  
 Form the above results and discussion of the study of Sangan Ver 
Pattai Chooranam, the hypothesis the sangan Ver Pattai was effective in 
curing Ayhal Keel Vayu” was statistically proved and accepted.       
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TABLE : 1.9 ILLUSTATING THE SEX DISRIBUTION 
Sl. No Sex No.of Patients Percentage 
1. Male 16 40% 
2. Female 24 60% 
 Total 40 100% 
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OVER ALL RESULTS OF TREATMENT 
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DISCUSSION 
DEFINITION ACCORDING TO SIDDHA TRADITIONAL 
TEXTS: 
 According to Siddha texts the disease “Azhal Keel Vayu” (Osteo 
arthritis) is caused by the increase of Valikkuttram in the body, and it 
appears due to excessive intake of foods and attitude having azhal nature. 
moy;fPy;thA: 
 ‘gpj;jf;fPy; tha;T jd;dhw; gpwq;FfPy; %l;L tPq;fpr; 
 rpj;jHnra; kUj;J tj;JQ; rPHglhj; jd;ikj; jhfpj; 
 jj;jW fha;r;ry; fz;L rhyNt jidjhd; je;Nj 
 nkj;jW rpfpr;ir jd;dhy; nkd;nky ePq;F kg;gh” 
       (-rghgjp ifNaL) 
      (Siddha Maruthuvam P.No.597) 
nghUs;: 
 ,J> tspf;Fw;wk; jd;dpiyapy; kpFe;Js;sNghJ> moy; 
Fw;wj;ijj; J}z;lf;$ba czT> nra;if Kjypatw;why; gpwf;Fk; 
NehahFk;. ,e;Nehapy;> Kl;bfspy; cz;lhFk; tPf;fk; ehSf;F ehs; 
ngUj;Jf; nfhz;Nl te;J> kpFe;j jPf;Fw;wj;jhy; fPy;fspdpilNaAs;s 
gir twz;L> giraw;Wf; fPy; mirAk; Nghnjy;yhk; el;ilAiljYk; 
‘fYf;” ‘fYf;” vd;w XH xyp cz;lhtJkha; ,Uf;Fk; rpyNtisfspy;> 
fPYf;Ff; fPy; $b xl;bf; nfhz;L> xU fop Nghy klf;f KbahkNy 
epd;WtpLtJk; cz;L. ,e;Nehapy; rpWRuKk; tUk;. 
 The above signs and symptoms are relieved clinically by the 
administration of the test drug (Sangan Ver Pattai Chooranam). The 
explanation is given below. 
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ACCORDING TO GUNAM: 
 Sangan Verpattai Chooranam is bitter in taste. According to 
panchabootham theory bitter taste is made up of Vayu (air) + Aagayam 
(Space). It has vappa veeriyam. Bitter taste is neutralized the Kabha and 
Pitha humours. 
ACCORDING TO ACTION: 
 The study of the sangan ver pattai Chooranam, according to Siddha 
concept of action have. 
 Stimulant  - to stimulate removal of fluids 
 Astringent  - to restrict further collection of fluids 
 Tonic   - to improve muscle tonic action on the  
affected place. 
 Antiperiodic  - to control inflammatory fever. 
ACCORDING TO BIO-CHEMICAL ANALYSIS: 
 Calcium is essential for growth, as it plays an important role in the 
formation of bones. 
 Sulphates – by converting toxic substances into non toxic 
materials by means of conjugation. 
 Iron combines with a protein and forms apoferritin which is 
converted into ferritin and is stored in this form largely. 
 Amino acids – sodium co-transport of amino acids also occurs 
during the absorption of amino acids from the intestine into the blood and 
during the reabsorption from renal tubule into blood. 
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ACCORDING TO PHARMACOLOGICAL ANALYSIS: 
 The study of the Sangan Ver Pattai Chooranam has got significant 
analgesic, significant acute anti inflammatory and significant anti pyretic 
activities. 
ACCORDING TO CLINICAL EVALUATION: 
 About 40 patients suffering from Azhal Keel Vayu in Govt. Siddha 
medical  College, Palayamkottai revealed that the patients showed, 
 Good response - 82.5% 
 Fair response - 12.5% 
 Poor response - 5% 
ACCORDING TO BIO-STATISTICAL ANALYSIS: 
 The drug Sangan Ver Pattai Chooranam has got significant effect 
in treating Azhal Keel Vayu which can be compared to Osteo arthritis.  
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SUMMARY 
The test drug sangan ver pattai chooranam has been selected for 
the study to establish its efficacy in treating Azhal Keel Vayu.  
The study of phytochemistry revealed that the drug Sangan Ver 
Pattai Chooranam is used for study were having the action which helps in 
anti-inflammatory ie., stimulant, astringent, tonic and anti-periodic 
actions.  
Bio – Chemical analysis shows that the test drug Sangan Ver Pattai 
Chooranam contains calcium, sulphate, chloride, starch, Ferrous iron, 
unsaturated compound and Amino acid.  
Pharmacological analysis shows that this drug has got significant 
analgesic, acute anti-inflammatory and anti-pyretic activities.  
Antimicrobial test report shows that this drug has got resistance to 
all the micro organisms.  
Clinical evaluation carried out on 40 patients suffering from Azhal 
keel vayu in Govt. Siddha Medical College Hospital, Palayamkottai 
revealed that the patients treated with sangan ver pattai chooranam had 
obtained excellent improvement.  
 Bio-statistical analysis also proved that this drug has got 
significant effect in treating Azhal Keel Vayu.  
 This may showed that the drug Sangan Ver Pattai Chooranam had 
potent action in relieving the signs and symptoms of Azhal Keel Vayu 
which can be compared to osteo arthritis.  
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CONCLUSION  
 
 With these results it can be concluded that the test drug Sangan 
Ver Pattai Chooranam had showed excellent results in relieving the 
signs and symptoms of the patients suffering from Azhal Keel Vayu, 
which can be compared to Osteo Arthritis.  
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A STUDY ON GANDAGA CHENDURAM 
INTRODUCTION  
  Siddha System of medicine is one among the ancient science 
which is propounded and practiced by eminent spiritual scientists called 
siddhers.  Siddhers are those who lived and maintained their bodies, as 
they desired best.  They had investigated that the body though transient 
was the one and only instrument for attaining success in the spiritual 
development and growth and so worked out to the Eight super natural 
powers, the Ashtamasiddhi, essential for their goal.  
 Siddhers further realized that if the body could only be made strong 
and perfect they could get rid of birth and death and live for ages 
together. 
 In Siddha system of medicine a close relation is maintained 
between nan and prabancham (the Universe) what ever changes occur in 
the Prabancham  influences the human body also.  It has been illustrated 
as, 
‘mz;lj;jpy; cs;sNj gpz;lk; 
gpz;lj;jpy; cs;sNj mz;lk; 
mz;lKk; gpz;lKk; xd;Nw 
mwpe;J jhd; ghh;f;Fk; NghNj’’  
        - rl;lKdp Qhdk;;.  
  Our unique system of Tamil medicine is based upon two main 
theories viz., Panchabootha theory and Tridosha theory.  
 According to Panchabootha theory the Universe is formed of five 
elements namely Prithvi, (Earth) Appu (water), Theyu (Fire), Vaayu 
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(Wind), and Agayam (Space) is formed of it in definite proportion.  This 
is explained as.  
‘epyk; ePh;jPtsp tpRk; Nghile;Jk; 
fye;j kaf;fk; cyfkhjypd;” 
- njhy;fhg;gpak;.  
According to Tridosha theory, the three components namely 
Vatham, Pitham, and Kabam. When in equilibrium keep the body in 
homeostasis but when vitiated either single or in combination bring about 
disease.   
‘kpfpDk; FiwapDk; Neha; nra;Ak; E}Nyhh; 
tsp Kjyh vz;zpa %d;W” 
- jpUf;Fws; 
 
Today India is acknowledged as an economy as we have rich 
heritage of land, water, natural resources etc, but rampant anaemia has 
been reported among youngsters, which is neither good for them nor for 
the economy.  
: India has highest number of cases of anaemia in world.  
:  Over 90% Indian women adolescent girls and children are   
anaemic  
:  Anaemia adversely affects a Childs mental and motor  
  development 
:  A poor diet   is the primary cause for anaemia.  
:  So control of iron deficiency anaemia in young children  
and adolescent is necessary to improve the quality of life     
for  youngsters.  
- The Hindu courtesy  
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AIM AND OBJECTIVE  
 The main aim and objective of this dissertation work is to do a 
scientific review of Gandaga Chenduram and the treatment of Pandu 
Noi on the basis of haematinic action.  
 Pandu noi is one of the common diseases affecting millions of 
people all over the world.  Gandaga chenduram is essential to find out a 
simple drug to overcome Pandu noi. The drug should be easily available 
economic, easily administered and also effective in smaller doses.  So the 
author has selected this drug for the dissertation purpose.  The chenduram 
was prepared based on the reference in the Siddha literature. 
     -  Bogar Elunooru Page No: 51 
 In this dissertation the analysis of Gandaga Chenduram is done 
in all aspects like.  
 :  Chemical aspect.  
 :  Gunapadam aspect. 
 :  Bio – Chemical analysis.  
 :  Pharmacological analysis 
          :  Toxicity study 
:  Heavy metals analysis 
 :  Anti-Microbial Analysis 
 :  Bio- Statistical Analysis 
 :  Clinical assessment.  
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REVIEW OF LITERATURE 
CHEMICAL ASPECT OF SULPHUR 
 
 Sulfur or sulphur is the chemical element that has the atomic 
number 16. It is denoted with the symbol S. It is an abundant multivalent 
non-metal. Sulfur, in its native form, is a yellow crystalline solid. In 
nature, it can be found as the pure element and as sulfide and sulfate 
minerals. It is an essential element for life and is found in two amino 
acids, cysteine and methionine. Its commercial uses are primarily in 
fertilizers, but it is also widely used in gunpowder, matches, insecticides 
and fungicides. Elemental sulfur crystals are commonly sought after by 
mineral collectors for their brightly colored polyhedron shapes. In 
nonscientific context it can also be referred to as brimstone. 
TABLE : 2.1 GENERAL INFORMATION OF SULPHURE 
Name, symbol, number Sulfur, S, 16 
Chemical series Nonmetals 
Group, period, block 16,3,p 
Appearance Lemon yellow crystals 
Standard atomic weight 32.065(5)g.mol-1 
Electron configuration (Ne) 3s2 3p4 
Electrons per shell 2,8,6 
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TABLE : 2.2 PHYSICAL PROPERTIES OF SULPHURE 
Phase Solid 
Liquid density at m.p 1.819g.cm-3 
Melting Point 388.36K 
(115.21oC, 239.38 oF) 
Boiling point 717.8 K 
(444.6 oC, 832.3 oF) 
 
HISTORY: 
 Sanskrit : Sulvari 
 Latin: Sulfur Surfur was known in ancient times, and is referred 
to in the Biblical Pentateuch.                           
 English translations of the Bible commonly referred to sulfur as 
“brimstone”, giving rise to the name of ‘fire and brimstone’ sermons, in 
which listeners are reminded of the fate of eternal damnation that awaits 
the unbelieving and unrepentant. It is from this part of the Bible that Hell 
is implied to “smell of sulfur”, although sulfur, in itself, is infact odorless. 
The “smell of sulfur” usually refers to either the odor of hydrogen sulfide,  
 In 1777 Antoine Lavoisier helped convince the scientific 
community that sulfur was an element and not a compound. In 1867, 
sulfur was discovered in underground deposits in Louisiana and Texas. 
The overlying layer of earth was quicksand, prohibiting ordinary mining 
operations, therefore the Frasch process was used. 
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CHARACTERISTICS: 
At room temperature, sulfur is a soft, bright – yellow solid. 
Elemental sulfur has only a faint odor, similar to that of matches. The 
odor associated with rotten eggs is due to hydrogen sulfide (H2S) and 
organic sulfur compounds rather than elemental sulfur. Sulfur burns with 
a blue flame that emits sulfur dioxide, notable for its peculiar suffocating 
odor due to dissolving in the mucosa to form dilute sulfurous acid. Sulfur 
itself is insoluble in water, but soluble in carbon disulfide – and to a 
lesser extent in other non-polar organic solvents such as benzene and 
toluene. Common oxidation states of sulfur include -2, +2, +4 and +6. 
Sulfur forms stable compounds with all elements except the noble gases. 
Sulfur in the solid state ordinarily exists as cyclic crown-shaped S8 
molecules. 
A noteworthy property of sulfur is that its viscosity in its molten 
state, unlike most other liquids, increases above temperatures of 200oC 
due to the formation of polymers. The molten sulfur assumes a dark red 
color above this temperature. At higher temperatures, however, the 
viscosity is decreased as depolymerization occurs. 
ISOTOPES: 
Sulfur has 18 isotopes, four of which are stable: 32S (95.02%), 
33S(0.75%), 34S (4.21%), and 36S (0.02%). Other than 35S, the radioactive  
isotopes of sulfur are all short lived. 35S is formed from cosmic ray 
spallation of40 argon in the atmosphere. It has a half-life of 87 days. 
OCCURRENCE:         
 Elemental sulfur can be found near hot springs  and volcanic 
regions in many parts of the world, especially along the Pacific Ring of 
Fire. Such volcanic deposits are currently mined in Indonesia, Chile, and 
Japan. Sicily is also famous for its sulfur mines. 
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           Common naturally occurring sulphur compounds include the 
sulphide minerals, such as pyrite iron (sulphide), cinnabar (mercury 
sulphide), galena (lead sulphide), sphalerite (zinc sulphide) and  stibnite 
(antimony sulfide); and the sulfates, such as gypsum (calcium sulfate), 
alunite (potassium aluminium sulfate), and barite (barium sulfate). It 
occurs naturally in volcanic emissions, such as from hydrothermal vents, 
and from bacterial action on decaying sulfur – containing organic matter. 
EXTRACTION AND PRODUCTION: 
EXTRACTION FROM NATURAL RESOURCES: 
 Sulfur is extracted by mainly two processes: the Sicilian process 
and the Frasch process. The Sicilian process, which was first used in 
Sicily, was used in ancient times to get sulfur from rocks present in 
volcanic regions. In this process, the sulfur deposits are piled and stacked 
in brick kilns built on sloping hillsides, and with airspaces between them. 
Then powdered sulfur is put on top of the sulfur deposit and ignited. As 
the sulfur burns, the heat melts the sulfur deposits, causing the molten 
sulfur to flow down the sloping hillside. The molten sulfur can then be 
collected in wooden buckets. 
 The second process used to obtain sulfur is the Frasch process. In 
this method, three concentric pipes are used: the outermost pipe contains 
superheated water, which melts the sulfur, and the innermost pipe is filled 
with hot compressed air, which serves to create foam and pressure. The 
resulting sulfur foam is then expelled through the middle pipe. 
 The Frasch process produces sulfur with a 99.5% purity content, 
and which needs no further purification. The sulfur produced by the 
Sicilian process must be purified by distillation. 
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PRODUCTION FROM HYDROGEN SULFIDE: 
CHEMICALLY: 
 The Claus process is used to extract elemental sulfur from 
hydrogen sulfide produced in hydrodesulfurization of petroleum or from 
natural gas. 
BIOLOGICALLY: 
 In the biological route, hydrogen sulfide (H2S) from natural gas r 
refinery gas is absorbed with a slight alkaline solution in a wet scrubber. 
Or the sulfide is produced by biological sulfate reduction. In the 
subsequent process step, the dissolved sulfide is biologically converted to 
elemental sulfur. This solid sulfur is removed from the reactor. This 
process has been built on commercial scale. The main advantages of this 
process are: 
1. No use of expensive chemicals. 
2. The process is safe as the H2S is directly absorbed in an alkaline 
solution. 
3. No production of a polluted waste stream, 
4. Re-usable sulfur is produced, and 
5. The process occurs under ambient conditions. 
The biosulfur product is different from other processes in which 
sulfur is produced because the sulfur is hydrophillic. Next to 
straightforward reuses as source for sulfuric acid production, it can also 
be applied as sulfur fertilizer.(11) 
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CHEMISTRY: 
INORGANIC COMPOUNDS: 
 Many of the unpleasant odors of organic matter are based on 
sulfur-containing compounds such as methyl and ethyl mercaptan, also 
used to scent natural gas so that leaks are easily detectable. The odor of 
garlic and “skunk stink” are also caused by sulfur-containing organic 
compounds. Not all organic sulfur compounds smell unpleasant; for 
example, grapefruit mercaptan, a sulfur-containing monoterpenoid is 
responsible for the characteristic scent of grapefruit. 
ORGANIC COMPOUNDS: 
¾ Thioethers have the form R-S-R′. These compounds are the 
sulfur equivalents of ethers. 
¾ Sulfonium ions have the formula RR′S-′R′′′,i.e. where three 
groups are attached to the cationic sulfur center. Dimethy- 
lsulfoniopropionate (DMSP; (CH3)2S+ CH2CH2COO-) is a 
sulfonium ion, which is important in the marine organic 
sulfur cycle. 
¾ Thiols (also known as mercaptans) have the form R-SH. 
These are the sulfur equivalents of alcohols. 
¾ Thiolates ions have the form R-S-. Such anions arise upon 
treatment of thiols with base. 
¾ Sulfoxides have the form R-S(=O)-R′. The simplest 
sulfoxide, DMSO, is a common solvent. 
¾ Sulfones have the form R-S(=O)2-R′. A common sulfone is 
sulfolane C4H8SO2. 
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APPLICATIONS: 
1. One of the direct uses of sulfur is in vulcanization of rubber. 
2. Elemental sulfur is mainly used as a precursor to other 
chemicals. Approximately 85% (1989) is converted to sulfuric 
acid (H2SO4),  
3. Sulfur compounds are also used in detergents, fungicides, 
dyestuffs, and agrichemicals.  
4. Sulfur is an ingredient in some acne treatments. 
5. An increasing application is as fertilizer. Standard sulfur is 
hydrophobic and therefore has to be covered with a surfactant 
by bacteria in the ground before it can be oxidized to sulfate. 
This makes it a slow release fertilizer, which cannot be taken up 
by the plants instantly.  
6. Sulfites, derived from burning sulfur, are heavily used to bleach 
paper.  
7. They are also used as preservatives in dried fruit. 
8. Magnesium sulfate, better known as Epsom salts, can be used as 
a laxative, a both additive, an exfoliant, a magnesium 
supplement for plants, or a desiccant. 
BIOLOGICAL ROLE: 
1. Sulfur is an essential component of all living cells. 
2. Inorganic sulfur forms a part of iron-sulfur clusters, and sulfur 
is the bridging ligand in the CuA site of cytochrome c oxidase, a 
basic substance involved in utilization of oxygen by all aerobic 
life. 
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3. Sulfur may also serve as chemical food source for some 
primitive organisms: 
4. Sulfur is a part of many bacterial defense molecules.  
5. In plants and animals the amino acids cysteine and methionine 
contain sulfur, as do all polypeptides, proteins, and enzymes 
which contain these amino acids.  
6. Disulfide bonds (S-S bonds) formed between cysteine residues 
in peptide chains are very important in protein assembly and 
structure.  
TRADITIONAL MEDICAL ROLE FOR ELEMENTAL SULFUR: 
 In traditional medical skin treatment which predates modern era of 
scientific medicine, elemental sulfur has been used mainly as part of 
creams to alleviate various conditions such as psoriasis, eczema and acne. 
The mechanism of action is not known, although elemental sulfur does 
oxidize slowly to sulfurous acid, which in turn (though the action of 
sulfite) acts as a mild reducing and antibacterial agent. 
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IRON 
CHEMICAL ASPECT 
Iron is a chemical element with the symbol Fe (Latin: ferrum) and 
atomic number 26. Iron is a group 8 and period 4 element. Iron is a 
lustrous, silvery soft metal. It is one of the few ferromagnetic elements. 
Iron and nickel are notable for being the final elements produced 
by stellar nucleosynthesis, and are therefore the heaviest elements which 
do not require a red giant or supernova for formation. Iron and nickel are 
therefore the most abundant metals in metallic meteorites and in the 
dense-metal cores of planets such as Earth. Iron and iron alloys are also 
the most common source of ferromagnetic materials in everyday use. 
TABLE : 2.3 GENERAL INFORMATION OF IRON 
Name, symbol, number Iron,Fe,26 
Chemical series Transition metals 
Group, period, block 8,4,d 
Appearance Lustrous metallic with a 
grayish tinge 
Standard atomic weight 55.845(2)g.mol-1 
Electron configuration [Ar] 3d6 4s2 
Electrons per shell 2,8,14,2 
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TABLE : 2.4 PHYSICAL PROPERTIES OF IRON 
 
 
 
 
 
 
 
 
 
 
OCCURRENCE:       
 Iron is believed to be the sixth most abundant element in the 
universe, formed as the final act of nucleosynthesis by carbon burning in 
massive stars. While it makes up about 5% of the Earth’s crust, the 
earth’s core is believed to consist largely of an iron-nickel alloy 
constituting 35% of the mass of the Earth as a whole. Iron is consequently 
the most abundant element on Earth, but only the fourth most abundant 
element in the Earth’s crust.(1) Most of the iron in the crust is found 
combined with oxygen as iron oxide minerals such as hematite and 
magnetite. About 1 in 20 meteorites consist of the unique iron-nickel 
minerals taenite (35-80% iron) and kamacite (90-95% iron). Although 
rare, meteorites are the major form of natural metallic iron on the earth’s 
surface. 
The reason for Mar’s red colour is thought to be an iron oxide rich 
soil. 
Phase Solid 
Density (near r.t.) 7.874g.cm-3 
Liquid density at m.p 6.98g.cm-3 
Melting point 1811 K 
(1538 oC, 2800oF) 
Boiling point 3134 K 
(2862 oC,5182 oF) 
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CHARACTERISTICS: 
 Iron is a metal extracted mainly from the iron ore hematite. It 
oxidises readily in air and water to form Fe2O3 and is rarely found as a 
free element. In order to obtain elemental iron, oxygen and other 
impurities must be removed by chemical reduction. The properties of iron 
can be modified by alloying it with various other metals and some non-
metals, notably carbon and silicon to form steels. 
 Iron (as Fe2+, ferrous ion) is a necessary trace element used by 
almost all living organisms. The only exceptions are several organisms 
that live in iron-poor environments and have evolved to use different 
elements in their metabolic processes, such as manganese instead of iron 
for catalysis, or hemocyanin instead of hemoglobin. Iron-containing 
enzymes, usually containing heme prosthetic groups, participate in 
catalysis of oxidation reactions in biology, and in transport of a number 
of soluble gases.  
IRON COMPOUNDS: 
¾ Iron oxides (FeO, Fe3O4, and Fe2O3) are ores used for iron 
production. They are common components of terrestrial 
rocks. 
¾ Iron (III) acetate (Fe(C2H3O2)3 is used in the dyeing of cloth. 
¾ Iron (III) ammonium oxalate (Fe(NH4)3 (C2O4)4) is used in 
blueprints. 
¾ Iron(III) arsenate (FeAsO4) is used in insecticide. 
¾ Iron (III) chloride (FeCl3) is used: in water purification and 
sewage treatment, in the dyeing of cloth, as a coloring agent 
in paints, as an additive in animal feed, and as an etching 
material for engravement, photography and printed circuits. 
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¾ Iron (III) chromate (Fe2(CrO4)3) is used as a yellow pigment 
for paints and ceramic. 
¾ Iron (III) hydroxide (Fe(OH)3) is used as a brown pigment 
for rubber and in water purification systems. 
¾ Iron (III) phosphate (FePO4) is used in fertilizer and as an 
additive in human and animal food. 
¾ Iron (II) acetate (Fe(C2H3O2)2 is used in the dyeing of fabrics 
and leather, and as a wood preservative. 
¾ Iron (II) gluconate (Fe(C6H11O7)2) is used as a dietary 
supplement in iron pills. 
¾ Iron (II) oxalate (FeC2O4) is used as yellow pigment for 
paints, plastics, glass and ceramic, and in photography. 
¾ Iron (II) sulfate (FeSO4) is used in water purification and 
sewage treatment systems, as a catalyst in the production of 
ammonia, as an ingredient in fertilizer and herbicide, as an 
additive in animal feed, in wood preservative and as an 
additive to flour to increase iron levels. Experimental iron 
fertilization of areas of the ocean using iron (II) sulfate has 
proven successful in increasing plankton growth. [5][6][7] 
¾ Iron-Fluorine complex (FeF6)3- is found in solutions 
containing both Fe(III) ions and fluoride ions. 
¾ Potassium Ferrate (K2FeO4) contains a tetra-oxo anion of 
iron in its highest known Oxidation State. 
HISTORY:                
 The first iron used by mankind  during prehistory came from 
meteors. The smelting of iron in bloomeries probably began in Anatolia, 
India or the Caucasus in the second millennium BC or the later part of the 
preceding one. Cast iron was first produced in China about 550 BC, but 
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not in Europe until the medieval period. During the medieval period, 
means were found in Europe of producing wrought iron from cast iron (in 
this context known as pig iron) using finery forges. For all these 
processes, charcoal was required as fuel.  
PRODUCTION OF IRON FROM IRON ORE: 
 The production of iron is a process unless the desired final product 
is cast iron. The first stage is to produce pig iron in a blast furnace. The 
second is to make wrought iron from pig iron. 
 Pig iron is not pure iron, but has 4-5% carbon dissolved in it with 
small amounts of other impurities like sulfur, magnesium, phosphorus 
and manganese. As the carbon is the major impurity, the iron (pig iron) 
becomes brittle and hard. This form of iron is used to cast articles in 
foundries such as stoves, pipes, radiators, lamp-posts and rails. 
 Alternatively pig iron may be made into steel (with up to about 2% 
carbon) or wrought iron (commercially pure iron). Various processes 
have been used for this, including finery forges, puddling furnaces, 
Bessemer converters, open hearth furnaces, basic oxygen furnaces, and 
electric arc furnaces. In all cases, the objective is to oxidise some or all of 
the carbon, together with other impurities. On the other hand, other 
metals may be added to make alloy steels. 
 The hardness of the steel depends upon its carbon content. The 
higher the proportion of carbon, the greater the hardness and the lesser 
the ductility. The properties of the steel can also be changed by tempering 
it. To harden the steel, it is heated to red hot and then cooled by 
quenching it in the water. It becomes harder and more brittle. This steel is 
then heated to a required temperature and allowed to cool. The steel thus 
formed is less brittle. 
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IRON IN BIOLOGY:  
Iron is essential to nearly all known organisms. In cells, iron is 
generally stored in the centre of metalloproteins, because "free" iron -- 
which binds non-specifically to many cellular components -- can catalyse 
production of toxic free radicals. Iron deficiency can lead to iron 
deficiency anemia. 
In animals, plants, and fungi, iron is often incorporated into the 
heme complex. Heme is an essential component of cytochrome proteins, 
which mediate redox reactions, and of oxygen carrier proteins such as 
hemoglobin, myoglobin, and leghemoglobin. Inorganic iron also 
contributes to redox reactions in the iron-sulfur clusters of many 
enzymes, such as nitrogenase (involved in the synthesis of ammonia from 
nitrogen and hydrogen) and hydrogenase. Non-heme iron proteins include 
the enzymes methane monooxygenase (oxidizes methane to methanol), 
ribonucleotide reductase (reduces ribose to deoxyribose; DNA 
biosynthesis), hemerythrins (oxygen transport and fixation in marine 
invertebrates) and purple acid phosphatase (hydrolysis of phosphate 
esters). 
Iron distribution is heavily regulated in mammals, partly because 
iron has a high potential for biological toxicity. Iron distribution is also 
regulated because many bacteria require iron, so restricting its availability 
to bacteria (generally by sequestering it inside cells) can help to prevent 
or limit infections. This is probably the reason for the relatively low 
amounts of iron in mammalian milk. A major component of this 
regulation is the protein transferrin, which binds iron absorbed from the 
duodenum and carries it in the blood to cells.[13] 
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NUTRITION AND DIETARY SOURCES: 
Good sources of dietary iron include red meat, fish, poultry, lentils, 
beans, leaf vegetables, tofu, chickpeas, black-eyed peas, fortified bread, 
and breakfast cereals. Iron in low amounts is found in molasses, teff and 
farina. Iron in meat is more easily absorbed than iron in vegetables (haem 
iron),[14] but hemoglobin from red meat has effects which may increase 
the likelihood of colorectal cancer.  
Iron provided by dietary supplements is often found as iron (II) 
fumarate, although iron sulfate is cheaper and is absorbed equally well. 
Elemental iron, despite being absorbed to a much smaller extent (stomach 
acid is sufficient to convert some of it to ferrous iron), is often added to 
foods such as breakfast cereals or "enriched" wheat flour (where it is 
listed as "reduced iron" in the list of ingredients). Iron is most available to 
the body when chelated to amino acids - iron in this form is ten to fifteen 
times more bioavailable than any other, and is also available for use as a 
common iron supplement. Often the amino acid chosen for this purpose is 
the cheapest and most common amino acid, glycine, leading to "iron 
glycinate" supplements. The RDA for iron varies considerably based on 
age, gender, and source of dietary iron (heme-based iron has higher 
bioavailability).[19] Infants may require iron supplements if they are not 
breast-fed. Blood donors and pregnant women are at special risk of low 
iron levels and are often advised to supplement their iron intake. 
REGULATION OF IRON UPTAKE:     
Excessive iron can be toxic, because free ferrous iron reacts with 
peroxides to produce free radicals, which are highly reactive and can 
damage DNA, proteins, lipids, and other cellular components. Thus, iron 
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toxicity occurs when there is free iron in the cell, which generally occurs 
when iron levels exceed the capacity of transferrin to bind the iron. 
Iron uptake is tightly regulated by the human body, which has no 
regulated physiological means of excreting iron. Only small amounts of 
iron are lost daily due to mucosal and skin  epithelial cell sloughing, so 
control of iron levels is mostly by regulating uptake. However, large 
amounts of ingested iron can cause excessive levels of iron in the blood 
because high iron levels can damage the cells of the gastrointestinal tract, 
preventing them from regulating iron absorption. High blood 
concentrations of iron  damage cells in the heart, liver and elsewhere, 
which can cause serious problems, including long-term organ damage and 
even death. 
Humans experience iron toxicity above 20 milligrams of iron for 
every kilogram of mass, and 60 milligrams per kilogram is a lethal 
dose.[21] Over-consumption of iron, often the result of children eating 
large quantities of ferrous sulfate tablets intended for adult consumption, 
is one of the most common toxicological causes of death in children 
under six. The DRI lists the Tolerable Upper Intake Level (UL) for adults 
as 45 mg/day. For children under fourteen years old the UL is 40 mg/day. 
Regulation of iron uptake is impaired in some people as a result of 
a genetic defect that maps to the HLA-H gene region on chromosome 6. 
In these people, excessive iron intake can result in iron overload 
disorders, such as hemochromatosis. Many people have a genetic 
susceptibility to iron overload without realizing it or being aware of a 
family history of the problem. For this reason, it is advised that people 
not take iron supplements unless they suffer from iron deficiency and 
have consulted a doctor. Hemochromatosis is estimated to cause disease 
in between 0.3 and 0.8% of Caucasians.  
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The medical management of iron toxicity is complex, and can 
include use of a specific chelating agent called deferoxamine to bind and 
expel excess iron from the body.  
HUMAN IRON METABOLISM 
 Human iron metabolism is the set of chemical reactions 
maintaining human homeostasis of iron. Iron is an essential element for 
most life on Earth, including human beings. The control of this necessary 
but potentially toxic substance is an important part of many aspects of 
human health and disease. Hematologists have been especially interested 
in the system of iron metabolism because iron is essential to red blood 
cells. Most of the human body’s iron is contained in red blood cell’s 
hemoglobin, and iron deficiency anemia is the most common type of 
anemia. 
 Understanding this system is also important for understanding 
diseases of iron overload, like hemochromatosis. 
 Recent discoveries in the field have shed new light on how humans 
control the level of iron in their bodies and created new understanding of 
the mechanisms of several diseases.  
IMPORTANCE OF IRON REGULATION: 
 Iron is an absolute requirement for most forms of life, including 
humans and most bacterial species. Because plants and animals all use 
iron, iron can be found in a wide variety of food sources. 
 Iron is essential to life, because of its unique ability to serve as 
both an electron donor and acceptor. 
 Iron can also be potentially toxic. Its ability to donate and accept 
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electrons means that if iron is free within the cell, it can catalyze the 
conversion of hydrogen peroxide into free radicals. Free radicals can 
cause damage to a wide variety of cellular structures, and ultimately kill 
the cell. To prevent that kind of damage, all life forms that use iron bind 
the iron atoms to proteins. That allows the cells to use the benefits of iron, 
but also limit its ability to do harm. 
 The most important group of iron-binding proteins contain the 
heme molecules, all of which contain iron at their centers. Humans and 
most bacteria use variants of heme to carry out redox reactions and 
electron transport processes. These reactions and processes are required 
for oxidative phosphorylation. That process is the principal source of 
energy for human cells; without it, our cells would die. 
 Humans also use iron in the hemoglobin of red blood cells, in order 
to transport oxygen from the lungs to the tissues and to export carbon 
dioxide back to the lungs. Iron is also an essential component of 
myoglobin to store oxygen in muscle cells. 
HOW THE BODY GETS ITS IRON:  
 Most of the iron in the body is hoarded and recycled by the 
reticuloendothelial system which breaks down aged red blood cells.  
However, people lose a small but steady amount by sweating and by 
shedding cells of the skin and the mucosal lining of the gastrointestinal 
tract.  The total amount of loss for healthy people in the developed world 
amounts to an estimated average of 1 mg a day for men, and 1.5-2 mg a 
day for women with regular menstrual periods.  People in develop-ping 
countries with gastrointestinal parasitic infections often lose more. 
This steady loss means that people must continue to absorb iron.  
They do so via a tightly regulated process that under normal 
circumstances protects against iron overload.  
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ABSORBING IRON FROM THE DIET : 
 Like most mineral nutrients, iron from digested food or 
supplements is almost entirely absorbed in the duodenum by enterocytes 
of the duodenal lining.  These cells have special molecules that allow 
them to move iron into the body.  
 To be absorbed, dietary iron must be in its ferrous Fe2+ form.  A 
ferric reductase enzyme on the enterocytes’ brush border, Dcytb, reduces 
ferric Fe3+  to Fe2+.  A protein called divalent metal transporter 1 DMT1, 
which transports all kinds of divalent metals into the body, then transports 
the iron across the enterocyte’s cell membrane and into the cell.  
 These intestinal lining cells can then either store the iron as ferritin 
(in which case the iron will leave the body when the cell dies and is 
sloughed off into feces) or the cell can move it into the body, using a 
protein called ferroportin.  The body regulates iron levels by regulating 
each of these steps.  For instance, cells produce more Dcytb, DMT1 and 
ferroportin in response to iron deficiency anemia  
 Our bodies’ rates of iron absorption appear to respond to a variety 
of interdependent factors, including total iron stores, the extent to which 
the bone marrow is producing new red blood cells, the concentration of 
hemoglobin in the blood, and the oxygen content of the blood.  We also 
absorb less iron during times of inflammation.  Recent discoveries 
demonstrate that hepcidin regulation of ferroportin is responsible for the 
syndrome of anemia of chronic disease. 
 While Dcytb and DMT1 are unique to iron transport across the 
duodenum, ferroportin is distributed throughout the body on all cells 
which store iron.  Thus, regulation of ferroportin is the body’s main way 
of regulating the amount of iron in circulation.  
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REASONS FOR IRON DEFICIENCY: 
Functional or actual iron deficiency can result from a variety of 
causes, explained in more detail in the article dedicated to this topic. 
These causes can be grouped into several categories: 
 Increased demand for iron, which the diet cannot accommodate. 
 Increased loss of iron (usually through loss of blood). 
 Nutritional deficiency. This can either be the result of failure to 
eat iron containing foods, or eating a diet heavy in food that 
reduces the absorption of iron, or both. 
 Inability to absorb iron because of damage to the intestinal 
lining. Examples of causes of this kind of damage include 
surgery involving the duodenum, or diseases like Crohn’s or 
celiac sprue which severely reduce the surface area available for 
absorption. 
 Inflammation leading to hepcidin-induced restriction on iron 
release from enterocytes. 
REGULATION BY LOCATION: 
 In summary, regulation of iron levels are a task of the whole body, 
as well as for individual cells. When body levels of iron are too low then 
hepcidin in the duodenal epithelium is decreased. This causes an increase 
in ferroportin activity, stimulating iron uptake in the digestive system. 
Vice versa in iron surplus. 
 In individual cells, an iron deficiency causes responsive element 
binding protein to iron responsive elements on mRNAs for transferrin 
receptors, resulting in increased production of transferrin receptors. These 
receptors increase binding of transferrin to cells, and therefore stimulating 
iron uptake. 
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DISEASES OF IRON REGULATION: 
 The exact mechanisms of most of the various forms of adult  
hemochromatosis, which make up most of the genetic iron overload 
disorders, remain unsolved. So while researchers have been able to 
identify genetic mutations causing several adult variants of 
hemochromatosis, they now must turn their attention to the normal 
function of these mutated genes. 
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GUNAPADAM ASPECT 
SULPHUR 
fe;jfk; 
NtWngaHfs;: 
 fhhpioapd; ehjk; 
 giu tPhpak; 
 mjPjg; gpufhrk; 
 gP[k; 
 nry;tptpe;J 
 rf;jp 
 rj;jpgPrk; 
 nre;J}uj;jhjp 
 jdk; 
 NjtpAuk; 
 ehjk; 
 ehw;wk; 
 giu ehjk; 
 nghd;tHzp 
 ,urRNuhzpjk; 
gpwg;G: 
 ghlhzq;fs; mWgj;J ehd;fpy; 
1. gpwg;Gf; fe;jfk; 
2. itg;Gf; fe;jfk; 
3. Nfhopj;jiyf; nfe;jp itg;G 
4. thznfe;jp itg;G 
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vd;W ehd;F ghlhzq;fs; $wg;gl;Ls;sd. ,tw;Ws; gpwg;Gf; 
fe;jfk; kiyapy; gpwf;fpd;w ruf;fhFk;. kw;w %d;Wk; gpwg;Gf; fe;jpapid 
Kjd;ikaha;f; nfhz;L kw;iwa ruf;Ffspd; cjtpahy; 
nra;ag;gLfpd;w ruf;FfshFk;. 
epwk;: 
 Nfhopj;jiyf; nfe;jpapd; epwk; - Nfhopj;jiyr; #l;bd; epwkhFk; 
kw;Wk; nfe;jf Ngjk; $Wkplj;J ehy;tif $wp ehy;tifr; rhjpf;F 
xg;gpl;L mitfspd; epwKk; gyDk; $wg;gl;Ls;sd. 
1. ntz;ik epwj;ij cilaJ - vy;yh Neha;fisAk; jPHf;Fk;. 
2. fpsp %f;Fr; rptg;G epwj;ij cilaJ - etNyhfj;ij 
Vkkhf;Fk;. 
3. nghd;ik epwj;ij cilaJ - Fw;wkw;w ney;ypf;fha; Nghd;W 
,Uf;Fk;. #jfj;NjhL cwthfpr; Rj;jkha; ,Uf;Fk;. 
4. fhfj;jpd; epwj;ijAilaJ - mfg;glhJ> mfg;gl;lhy; 
eiujpiufs; mw;Wg;Nghk;. 
gjhHj;j Fz rpe;jhkzpapy; ney;ypf;fha;f; fe;jfk;> thz fe;jfk; 
,itfspd; Fzq;fs; khj;jpuk; $wg;gl;bUf;fpd;wd. kUe;Jfspy; 
ifahsg;gLtJ ney;ypf;fha;f; fe;jfkhFk;. 
,Ug;gplk;: 
 Nehghsk;> fh\;kPH> Mg;fhdp];jhdk;> gHkh Kjypa ,lq;fspy; 
fe;jfk; fpilf;fpd;wJ. jhJ jhtu [Ptg; nghUs;fspYk; fe;jfk; 
fyg;Gw;wpUf;fpd;wJ. 
el;G kw;Wk; gifr; ruf;F: 
  ‘nrhy;YNk jhk;gpuj;ijf; nfe;jp nfhy;Yk;” 
  ‘fe;jpf;fpdK kpure;jh ndd;whNu” 
  77
vd;w mbfshy; fe;jfj;jpw;F jhk;gpuk; gifr;ruf;F vd;Wk;> ,urk; 
el;Gr; ruf;F vd;Wk; mwpayhk;. 
 ‘nre;J}ue; jdf;fhjp rpiy nfe;jp jhsfKk;” vd;w mbahy; 
nre;J}uk; nra;tjw;Ff; fe;jfk; cgNahfkhFk; vd;gjid mwpayhk;. 
Rit: ifg;G> JtHg;G 
nra;if: 
¾ gpj;jePiu mjpfg;gLj;Jk; 
¾ kykpsf;fp 
¾ cly;Njw;wp 
¾ tpaHitg; ngUf;fp 
¾ fpUkpehrpdp 
rpwpa mstpy; cs;Sf;F mUe;j: 
 m/J clk;gpy; NrHe;J tpaHit> ghy;> rpWePH ,tw;wpd; thapyhf 
ntspg;gLtijf; fhzyhk;. Njhy;> mRfq;fspd; rsp rt;tpYs;s 
Nfhsq;fspd; Rug;ig mjpfg;gLj;Jk;. tpNufpapy; rpwg;ghfr; nray;gl;L 
Rug;ig mjpfg;gLj;Jk; mjpf mstpy; mUe;j Ngjpia cz;Lgz;Zk; 
fe;jfq;fspd; nghJf;Fzk; 
ney;ypf;fha;f; fe;jfj;jpd; Fzk; 
  ‘ney;ypf;fha;f; fe;jpf;F ePs;gjpnzd; Fl;lke;jk; 
   ty;iy ftpirFd;k thAfz;Nzha; - nghy;yh 
   tplf;fbtd; NkfNeha; tPWRuk; Ngjp 
   jplf;fpuf zPfgk;Nghe; NjH.” 
(nghUs;) 
ney;ypf;fha;f;  fe;jfj;jpdhy; gjpndz;Fl;lk;> ke;jk;> fy;yPuy; 
tPf;fk;> ngUtapW tiffSs; xd;whfpa ftpir> Fd;kthA> 
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fz;Nzha;fs;> nfhLikiar; nra;fpd;w tplf;fbfs;> ehl;gl;l 
NkfNeha;fs;> thjRuk;> Ngjp> ehl;gl;l fpufzp> fgk; Kjypad ePq;Fk;. 
thzf; fe;jfj;jpd; Fzk; 
  ‘thzf; Foha;f;fe;jp thridiaf; fz;lTld;  
fhzf; fpUkp nrhwp fhzhthk; - NjhZk; 
ngUtpah jpf;$l;lk; NgU kjD}ypd; 
kUtpah Oq;nfhbNa tho;j;J” 
(nghUs;) 
thz kUe;Jf;fhd Foha;f; fe;jfj;jpd; thridiaf; 
fz;lTld; ,ur> ,uj;j jhJf;fspy; gpwe;j fpUkpfs; nrhwp> Fiw 
Neha;f; $l;lq;fs; ePq;Fk; vd;g. kw;Wk; ,jid ehs;gl;l fPy;thjk;> 
Rthr fhrk;>  khuilg;G> ,Uky;> fz;lkhiy> %yk;> Fjnefpo;r;rp 
Nghd;w Neha;fSf;Fk; cgNahfpg;gJz;L. 
fe;jfk;> jha; kfit tsHg;gJ Nghy Neha;fspd; ntg;gj;ij 
khw;wp clk;igj; Njw;Wtpf;Fk; vd;gij> 
‘khjH kfit tsHg;gJNgh NyAlk;ig 
ahjuth fj;Njw;wp ahf;ifapdhy; - kPjhf 
Nktp alHNehapd; ntg;gj;ij khw;Wjyhw; 
NwtpAu nkd;gJly; NjH” 
vd;Dk; Njud; nghUl;gz;G E}ypy; $wg;gl;l nra;Ashy; mwpf. 
Rj;jp Kiwfs; 
 Gspak;go Nthl;ilg; gw;wpapUf;Fk; frpit Cw itj;jpWj;j ePH> 
fhbePH> Gspj;jNkhH> fhshd;rhW ,itfisj; jdpj;jdp MWgykhf 
(210 fpuhk;) vLj;Jf; fye;J> xU rl;bapypl;L mr;rl;bf;Fr; rPiyapdhy; 
VL fl;b> mjd;Nky; xU gyk; (35 fpuhk;) fe;jfj;ij itj;J Nky;%b> 
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mLg;Ngw;wpj; jPghf;fpdpahy; ,uz;L rhkk; (6 kzpNeuk;) vhpf;f> kypdk; 
Nky; jq;fp fe;jfk; Rj;jpahfpf; fPopwq;Fk; vd;g. 
(NtW) 
 kUNjhd;wpf; fw;fj;ijg; gRtpd; japhpy; fye;J> xU rl;bapypl;Lr; 
rPiyahy; VL fl;b> Nky; fe;jfj;ij itj;J kw;nwhU rl;bahy; %br; 
rPiy nra;J> Fopapy; Gijj;J> Nky; rl;bNky; Ie;J tul;b nfhz;L 
Glkpl> fe;jfk; cUfpf; fPopwq;Fk;. Nrfhpj;Jf; nfhs;sTk;. ,t;tpjk; VO 
Kiw nra;aTk;. 
(NtW) 
 fe;jfj;ij xU ,Uk;Gf; fuz;bapypl;Lr; rpwpJ gRntz;nza; 
,l;;L cUf;fpg; gRk;ghypy; rha;f;fTk;. ,t;tpjk; 30 Kiw nra;af; 
fe;jfk; Rj;jp MFk;. xt;nthU KiwAk; Gjpa ghiyNa cgNahfpf;f 
Ntz;Lk;. 
(NtW) 
 ghYf;Fg; gjpy;> thiof;fl;il ePhpy; nfe;jpiag; gj;J Kiw 
cUf;fp cUf;fpr; rha;j;njLf;fr; Rj;jpahk;. ,k;Kiwahy; 
fe;jfj;jpYs;s vz;nza; ePq;Fk; vd;Wk; $WtH. 
msT 
 ,jid 10 (650 kp.fpuhk;) Kjy; 30 cSe;njil (1.9fpuhk;) tiu 
nfhLf;fyhk;. 1 (4.2 fpuhk;) Kjy; 3 tuhfndil (12.6 fpuhk;) nfhLf;f 
kyk; fopAk;. 
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fe;jfk; NrUk; ghz;L Neha;f;fhd kUe;Jfs; 
1. mafhe;jr; nre;J}uk;: Fzghlk; jhJ   (g.vz;: 73) 
     lhf;lH.MH. jpahfuh[d;> L.I.M. 
 msT  :  gzntil (488 kp.fpuhk;) 
 jPUk; Neha; :  ghz;L 
2. jphpNyhfr; nre;J}uk;: Fzghlk; jhJ   (g.vz;: 84) 
   lhf;lH.MH. jpahfuh[d;> L.I.M. 
msT  :   gzntil (488 kp.fpuhk;) 
mDghdk; :  rQ;rPtp #uzj;Jld; NrHj;J nea;apy;  
kj;jpj;J  cz;zTk;. 
jPUk; Neha;fs;  
NkfePH> ghz;L> gpj;jk;> gpuNkfk;> thA> cl;#L> ,Uky; ePq;Fk; 
Njfk; FspUk;. 
3. jz;lthsr; nre;J}uk; : Fzghlk; jhJ      (g.vz;: 120) 
    lhf;lH.MH. jpahfuh[d;> L.I.M. 
Fzk;: 
 rPuz Ruk;> mjprhuk; fpuhzp> mf;fpdp ke;jk;> %yk;> Fd;kk;> 
ghz;L Kjypa Neha;fSf;F Muk;g fhyj;jpYk;> Neha; ePq;Fk;. gpd;Dk; 
mtw;wpd; ry;ypak;> ,uj;jf;FiwT ,itfs; ePq;fTk;> cly; tYf;fTk; 
nfhLf;fyhk;. Neha; gykha; ,Uf;Fk;NghJ nfhLf;ff;$lhJ. 
4. cNyhfkz;^ur; nre;J}uk; : Fzghlk; jhJ     (g.vz;: 147) 
   lhf;lH.MH. jpahfuh[d;> L.I.M. 
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msT   :  2 gzntil ( 976 kp.fpuhk;) 
JizkUe;J : jphpfLF #uzj;jpy; Njd; tpl;Lf; fye;J  
  cl;nfhs;sTk;.  
jPUk; Neha;fs; 
,jdhy; tp\g;ghz;L> mWtiff; fhkhiy> ghz;L> gpj;jk;> 
fgNeha;> njhz;Z}w;whW mNuhrfk;> md;dj;JNt\k;> the;jp> tpf;fy;> 
thA> ePHj;Njhlk; ePq;Fk;. tpe;J CWk;. Njfk; ,WFk;. ntz;zpwj;ij 
mile;j Njfk; fUepwj;ij milAk;. 
5. fe;jfr; nre;J}uk; : Fzghlk; jhJ    (g.vz;: 235) 
   lhf;lH.MH. jpahfuh[d;> L.I.M. 
msT  :  2 (130 kp.fpuhk;) Kjy; 4 cSe;njil  
(260 kp fpuhk;)  
mDghdk; :  Njd;> ,Q;rpr;rhW. 
jPUk; Neha;fs; 
fhkhiy> Nrhig> ghz;L> ngUtapW> ePHngUtapW> fpufzpapy; 
tPf;fk;> Ngjp> mrPuzk; KjypadthFk;. 
6. fe;jf tlfk; : Fzghlk; jhJ       (g.vz;: 238) 
lhf;lH.MH. jpahfuh[d;> L.I.M. 
msT     :   1 khj;jpiu 
 jPUk; Neha;fs; :   ghz;L> ~ak;> %yf;fpuhzp Kjypad 
  82
7. gpujhghf;fpdp G+gjp : rpj;jitj;jpaj; jpul;L        (g.vz;: 56) 
    lh.f.eh.Fg;Grhkp KjypahH> H.P.I.M. 
lh.f.R. cj;jkuhad;> H.P.I.M.   
msT  :  Fd;wpasT khj;jpiu 
jPUk; Neha;fs; 
thjk; 84> 9 tif Ruk;> Rthrk;> fhkhiy> ghz;L> ~ak; 
,itfs; jPUk;. 
8. G+uz re;jpNuhjak; : rpj;jitj;jpaj;jpul;L         (g.vz;;;:58) 
     lh.f.eh.Fg;Grhkp KjypahH> H.P.I.M. 
lh.f.R. cj;jkuhad;> H.P.I.M. 
msT  :   gawsT khj;jpiu 
jPUk; Neha;fs; 
~ak;> 8 tif Fd;kq;fs;> Rthr fhrk;> ghz;L> Nrhig> 13 tif 
rd;dpfs;> ,e;jphpa e\;lk; ,itfs; jPUk;. 
9. maf;fhe;jr; nre;J}uk; : rpj;j itj;jpaj; jpul;L    (g.vz;: 132) 
     lh.f.eh.Fg;Grhkp KjypahH> H.P.I.M. 
lh.f.R. cj;jkuhad;> H.P.I.M. 
msT  :  gz vil (488 kp.fpuhk;) 
jPUk; Neha;  
ghz;L 
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10. MWKfr;nre;J}uk; : rpj;j itj;jpaj; jpul;L              (g.vz;: 134) 
     lh.f.eh.Fg;Grhkp KjypahH> H.P.I.M. 
lh.f.R. cj;jkuhad;> H.P.I.M. 
msT  : gz vil (488 kp.fpuhk;) 
mDghdk; : jphpfLFj; J}Sld; NrHj;J Njdpy; nfhLf;fTk;. 
jPUk; Neha;fs;  
miuthjk;> tpiuthjk;> mWtif %yk;> vhpFd;kk;> twl;rp> 
mdy;> ntb#iy> khHGr;#iy> fHg;gNuhfk;> ghz;L> Nrhif> fpue;jp> 
Fly;thjk;> thjgpj;jk;> rak;> miuahg;G> kjk;> mjprhuk;> kz;ilapb> 
njhz;iltyp> fz;lkhiy> twl;#iy> #iy ,itfs; jPUk;. 
11. fhe;jr; nre;J}uk; : rpj;j itj;jpaj;jpul;L       (g.vz;:142) 
     lh.f.eh.Fg;Grhkp KjypahH> H.P.I.M. 
lh.f.R. cj;jkuhad;> H.P.I.M. 
msT  : 1 Fd;wpkzp msT 2 Ntis 
mDghdk; : Njd; 
jPUk; Neha;fs; 
tp\ghz;L> ftpirf;fl;b> Nrhif> gpj;jg;ghz;L> ePuhk;gy;> 
mz;ltha;T> Mde;jtha;T ,d;dk; gpw tha;TfSk; ePq;fpg; Nghk;.  
ngz; ,r;iria ePf;f Ntz;Lk;. 
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12. fThp rpe;jhkzpr; nre;J}uk;: rpj;j itj;jpaj; jpul;L (g.vz;:143) 
     lh.f.eh.Fg;Grhkp KjypahH> H.P.I.M. 
lh.f.R. cj;jkuhad;> H.P.I.M. 
msT  : Fd;wpkzp msT 
mDghdk; : vUf;fpiy gOg;ig thl;bg; gpope;j rhw;wpy; ehs;tpl;L ehs;  
  cz;zTk;. 
jPUk; Neha;fs; 
tp\ghfk;> Nrhif> fhkhiy> gapj;jpak;> ghz;L> ePHf;Nfhit> 
Ruk;Nghk;. 
13. fhe;jr; nre;J}uk;: rpfpr;rhuj;ejPgk; ,uz;lhk; ghfk;        (g.vz;:238) 
- rp. fz;Zrhkpg;gps;is.  
MsT : Ntisf;F 1> 1½ Fd;wp vil 
 mDghdk; : Njd; 
jPUk; Neha;fs; 
ghz;L> ftpir> Nrhig> gpj;jghz;L> mz;lthA Kjypad. 
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fe;jfk; NrUk; gpw Neha;fSf;fhd kUe;Jfs;> msT kw;Wk; jPUk; 
Neha;fs; 
1. jq;f cuk ; : Fzghlk; jhJ        (g.vz;: 158)
  
lhf;lH.MH. jpahfuh[d;> L.I.M. 
msT  : 130 kp.fpuhk; Kjy; 260 kp.fpuhk; tiu 
jPUk; Neha;fs; 
 ,J Mz;> ngz; [dd cWg;Gfisg; gw;wpa Neha;fspy; 
gad;gLj;jg;gLfpwJ.  
2. nts;sp cuk; : Fzghlk; jhJ        (g.vz;: 159) 
     lhf;lH.MH. jpahfuh[d;> L.I.M. 
msT  : ½ (65 kp.fpuhk;) Kjy; 1 Fd;wp (130 kp.fpuhk;) tiu 
mDghdk; : [hjpf;fha; Nyfpak; 
jPUk; Neha;fs; 
,jdhy; jhJ tpUj;jp mile;J euk;Gfs; tYtilAk;. 
3. ,urr;nre;J}uk; : Fzghlk; jhJ         (g.vz;:193) 
     lhf;lH.MH. jpahfuh[d;> L.I.M. 
,ij rfy Neha;fSf;Fk; nfhLf;fyhk;. 
4. rpuq;Fg; G+r;R : Fzghlk; jhJ        (g.vz;: 200) 
     lhf;lH.MH. jpahfuh[d;> L.I.M. 
ntspg;gpuNahfkhf : rpuq;F> Gz;zpw;f;F gad;gLj;jyhk;.  
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5. fe;jf nkOF : Fzghlk; jhJ         (g.vz;:236) 
     lhf;lH.MH. jpahfuh[d;> L.I.M. 
msT  : 2 (260 kp. fpuhk;) Kjy; 3 Fd;wp (390 kp.fpuhk;) tiu 
jPUk; Neha;fs; 
ntF %j;jpuk; Nghd;w Nkf ePH Nuhfq;fs;> nrhwp> rpuq;F> Fl;lk;> 
%yk; Kjypad. 
6. fe;jf khj;jpiu : Fzghlk; jhJ       ( g.vz;: 236) 
     lhf;lH.MH. jpahfuh[d;> L.I.M. 
msT  : gawsT khj;jpiu 
jPUk; Neha;fs; 
ehl;gl;l Ruk;. 
7. fe;jfj; japyk; : Fzghlk; jhJ        (g.vz;: 237) 
msT  : ½  ( 244kp.fp) gzvil fhiy> khiy> ,UNtis10 ehs; 
JizkUe;J: rHf;fiu 
jPUk; Neha;fs; 
Fl;lk;> nrhwp> tpuzk;> nts;is> fUNkfk;> thjk;> thA> ~ak;> 
Fd;kk; Kjypad. 
8. fe;jf urhadk;: Fzghlk; jhJ              (g.vz;:238) 
     lhf;lH.MH. jpahfuh[d;> L.I.M. 
msT  : 10 Kjy; 15 Fd;wp tiu 
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jPUk; Neha;fs; 
Nkf Neha;fs;> %j;jpuf; fphPr;ruk;> Fl;lk;> fpufzp> %yk;> Fd;kk;> 
thjk;> tPf;fk; KjypadthFk;. 
9. gQ;r gh\hzr; nre;J}uk; : Fzghlk; jhJ       (g.vz;:258) 
      lhf;lH.MH. jpahfuh[d;> L.I.M. 
msT  : 1 gz vil (488 kp.fpuhk;) 
mDghdk; : Njd;> ,Q;rpr;rhW. 
jPUk; Neha;fs; 
rd;dp> Ruk;> ntz;Fl;lk;> #iy> thA> thjk;>  
10. kpUjhH rpq;fpr; nre;J}uk; : Fzghlk; jhJ     (g.vz;: 266) 
msT  : gzvil (488 kp.fp) 
JizkUe;J: Njd;> ntz;nza; 
jPUk; Neha; 
rfy Nkf tpuzq;fSk; ePq;Fk;. 
gj;jpak;: ,r;rhgj;jpak; 
11. gwq;fpg;gl;il urhadk;: NghfH - 700   (g.vz;:41) 
jPUk; Neha;fs; 
 fpue;jp> miuahg;G> Fl;lk;> 18 Fl;lNuhfk;> ,Lg;Gr;#iy> 
iffhy;Klf;F> gpuNkfk;> nts;is> Nkf Cwy;> ,ypq;fg;Gw;W> thjk;> 
Nahdpg;Gw;W> fd;dg;gw;W> tha;T> 18 #iy. 
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12. rq;fu igut khj;jpiu : rpfpr;rh uj;ejPgk; ,uz;lhk; ghfk; (g.vz;:170) 
- rp.fz;Zrhkpg;gps;is  
msT  : gawsT khj;jpiu 
mDghdk; : Njd;> ,Q;rpRurk; 
jPUk;Neha; 
  [d;dp> Ruk; 
13. NfhlhRop khj;jpiu : rpfpr;rh uj;ejPgk; ,uz;lhk; ghfk; (g.vz;:171) 
       -rp. fz;Zrhkpg;gps;is 
msT  : kpsfsT khj;jpiu 
JizkUe;J: ,Q;rpRurk;> Njd; 
jPUk;Neha; 
Ruk;> re;ep Kjypatw;Wld; Fj;jy;> Filr;ry;> gf;fNeha;> 
khuilg;G Kjypad. 
14. rptdhH mkpHjk; vd;Dk; ePyfz;l urk;: rpfpr;rh uj;ejPgk; ,uz;lhk;  
ghfk; (g.vz;:246) 
- rp. fz;Zrhkpg;gps;is  
msT  : ½ Fd;wpg; gpukhzk; 
mDghdk; : Njdpy; jpdk; 2 Ntis 
jPUk; Neha;  
[d;dpghjRuk;> fgRuk;> Njh\Ruk;> fgthj Ruk;> gpj;j rPjs Ruk;> 
khwy; Ruk; Kjypaitfs; 3 ehs; 6 Ntisapy; FzkhFk;.  
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15. re;epghj igut urk; : rpfpr;rh uj;ejPgk; ,uz;lhk; ghfk; (g.vz;:252) 
- rp. fz;Zrhkpg;gps;is  
msT  : mhprp vil 
mDghdk; : gidnty;yk; 
jPUk;Neha; 
[d;dp  
16. ,urfe;jp nkOF : rpfpr;rh uj;ejPgk; ,uz;lhk; ghfk; (g.vz;:255) 
- rp. fz;Zrhkpg;gps;is  
msT  : Njw;whq; nfhl;ilg; gpukhzk; jpdk; 2 Ntis 20 ehs; 
 
jPUk; Neha; 
F\;lk;> jpkpH> fz;lkhiy> Nkf#iy> fpue;jp> miuahg;G> Gw;W> 
fUk;Gs;sp> NkfCwy;> glHjhkiu> gTj;jpuk;> Foptpuzk;> njhil 
thio Kjypa gpzpfs; jPUk;. 
gj;jpak;: Gsp js;sp ,r;rhgj;jpak; my;yJ Nkhud;dk;. 
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mak; 
FERRUM (IRON) 
GUNAPADAM ASPECT. 
NtWngaHfs;: 
 mfp   
 maR     
 mapy;     
 ,b     
 ,Uk;G    
 <.rnrak; 
 fUq;nfhy; 
 fUg;gp 
 fUk;gp 
 fUk;G 
 fUg;G 
 fUkzy; 
 fUk;nghd; 
 faR 
 fpU\;zitak; 
 fhypy; nefpsk; 
 Mjp 
 rj;J 
 rpNuhruk; 
 rpl;lk; 
 jpUk;gp 
 Jz;lk; 
 gpz;lk; 
 nghd;kzy; 
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 Nyhfk; 
 tho;G+kpehjk; 
 fUe;jhJ 
- Fzghlk; jhJ -rPt tFg;G 
     (,uz;lhk; %d;whk; gFjpfs; g.vz;.64) 
 thjg;gr;ir 
 epUk;nghd; 
 RUk;nghd; 
 JUk;nghd; 
 fjfk; 
 jhk;gurq;fk; 
 jpUk;gd; 
Ref: gQ;r fhtpa epfz;L g.vz;: 109  
 mfp   
 maR     
 mapy;     
 ,b     
 ,Uk;G    
 <.rnrak; 
 fUq;nfhy; 
 fUg;gp 
 fUk;G 
 fUg;G 
 fUkzy; 
 fUk;nghd; 
 faR 
 fpU\;zitak; 
 fhypy; nefpsk; 
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 Mjp 
 rj;J 
 rpNuhruk; 
 rpl;lk; 
 jpUk;gp 
 Jz;lk; 
 gpz;lk; 
 nghd;kzy; 
 Nyhfk; 
 tho;G+kpehjk; 
 fUe;jhJ 
vd;w NtWngaHfspdhYk; toq;fg;gLk; 
Ref: NghfH epfz;L g.vz;: 105 
 ma]; 
 Nyhfk; 
vd;w ngaHfSk; cz;L 
Ref: uruj;d rKr;rak; g.vz;: 62 
,Ug;gplk;: 
 mak; vy;yh kiyfspYk;> epyq;fspYk;> mNefkhf fe;jfk; 
Nghd;w rpy nghUs;fSld; fyg;Gw;Wf; fpilf;fpd;wJ. ,J> jhJ jhtu 
[Ptg; nghUs;fspy; rpwpjsT fye;Jk; ,Uf;fpd;wJ. 
gifr;ruf;Ffs;: 
 mz;lNthL 
 mg;gpufk; 
 fe;jp 
 fpspQ;rNyhL 
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 nfshp 
 rt;tPuk; 
 rhuk; 
 rpq;fp 
 rpyhrj;J 
 rpiy 
 juh 
 epkpis 
 G+ePW 
 tq;fk; 
 ntq;fhuk; 
 ntz;fyk; 
 nts;isg; ghlhzk; 
el;Gr;ruf;Ffs;: 
 ,uh[tHj;jk; 
 fhe;jk; 
 nfe;jpr; nrk;G 
 #ld; 
 nrk;G 
 jq;fk; 
 ehfk; 
 G+ehfk; 
 G+uk; 
 kA+ur; nrk;G 
 nts;sp 
Ritfs;: 
 ngUk;ghd;ik: JtHg;G 
 rpWghd;ik: Gspg;G> ifg;Gr;Rit 
tPhpak;: ntg;gk; 
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nra;if: 
 grpAz;lhf;fp  (Stomachic) 
 cly; cukhf;fp (Tonic) 
 FUjpg; ngUf;fp (Haematinic) 
 cly; Njw;wp (Alterative) 
 mak; FUjpapd; jd;ikia Nkk;gLj;Jk;. ma rk;ge;jg;gl;l 
kUe;Jfs; kyf;fl;il cz;Lgz;Ztjpdhy; mijj; jtpHf;f Kg;giy 
$l;bf; nfhLg;gJ tof;fk;. clypd; vy;yh cWg;Gfspd; njhopy;fisAk; 
J}z;Ltpf;Fk;. ,jdhy; ,J cly;Njw;wpahfj; njhopy; Ghpfpd;wJ. 
nghJf;Fzk; 
 ‘ghz;Lntz; Fl;lk; gUe;J}y Neha;Nrhig 
 khz;blr;nra; ke;jq;fh khiyFd;kk; G+z;l 
 ngUe;jhJ el;lKk;Nghk; Ngjpgrp Az;lhq; 
 fUe;jhJ el;lkpLq; fhy;.” 
(nghopg;Giu) 
 ,Uk;gpdhy; gpj;j ghz;L> ntz;Fl;lk;> mjpJ}yNeha;> Nrhig> 
ke;jk;> fhkhiy> Fd;kk;> Rf;fpyel;lk;> fopr;ry; ,it ePq;Fk;. grp 
cz;lhFk;. 
 kw;Wk;> ‘,isj;jtH ,Uk;ig cz;z Ntz;Lk;” vd;w tpjpapid 
‘va;g;Glw; fpUk;ig Az;kpd;” vd;Dk; gonkhopahy; mwpf. 
  ‘gdKkhd NrhigNahL ghz;L jhDk; 
  Mf;FkNj fharpj;jp Nyhf rpj;jp 
  cj;jke;jhd; fhkhiyg; ghz;L Nrhif”. 
 Ref: NghfH 7000 3-k; ghfk; g.vz;: 275 
  ‘ghz;LNuhfk;> rpNyj;Jkk; ghwpapLk; cw;gd”. 
 Ref: mf];jpaH kzp 4000 ,uz;lhk; ghfk; g.vz;:296 
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Rj;jp Kiwfs; 
 xU gyk; (35 fpuhk;) mag;nghbf;F MW gyk; (210 fpuhk;) 
,Yg;igg; G+r;rhWtpl;L> fhiy Kjy; khiy tiu ntapypy; itf;f 
Ntz;Lk;. ,t;tpjk; MWehs; nra;J> ,uz;L ehs; rhWtplhky; 
cyHj;jp> gpd;Dk; ,ijg;Nghy ,Ukiw nra;J> 25 Mk; ehs; Kjy; gj;J 
ehl;fs; ,iltplhky; Nkw;gb rhWtpl;L> ntapypy; itj;Jg; gpd;G> 
rhWtplhky; ,uz;L ehs; cyHj;jp ePHtpl;Lf; fOtp vLf;fr; Rj;jpahk;. 
NtW 
 xU gyk; maj;ij xU ghz;lj;jpypl;L> mj;Jld; my;yp NtH 
vl;L gyKk; (280 fpuhk;) Gd;id NtH vl;L gyKk; (280 fpuhk;)> ,bj;Jg; 
Nghl;L gjpdhW gyk; (560 fpuhk;) fhb tpl;L ,uTk; gfYk; 
jPghf;fpdpaha; vhpf;f Ntz;Lk;. mg;gb vhpf;Fk;NghJ fhb 
Fiwe;Jtpl;lhy;> kWgbAk; mNj msT fhb thHj;J vhpf;f Ntz;Lk;. 
mg;gb vhpj;jhy; mak; Rj;jpahFk;. 
NtW 
 maj;ijf; nfhy;yd; ciyapypl;Lr; rptf;ff; fha;r;rp> MWkhj 
md;df;fhb> vz;nza;> Mtpd;ePH> nfhs;FbePH> ,e;ehd;fpYk; KiwNa 
Kk;%d;W Kiw Njha;j;Jj; Njha;j;njLj;Jf; fOtpf; nfhs;sr; 
Rj;jpahk;. myk;Gjw;F xt;nthU KiwAk; Gjpa ePiuNa cgNahfpf;f 
Ntz;Lk;. 
NtW 
 ,Uk;gpd; mug;nghbia> vYkpr;rk;gor;rhW> fhb> ehl;Lf; 
fhl;lhkzf;Fg;ghy; ,it xt;nthd;wpYk; %d;W ehs; Cwitj;Jf; 
fOtp vLf;fr; Rj;jpahk;. 
NtW 
 mag;nghbf;F ehtw;gor; rhw;iw %o;Fk;gb tpl;L> rhW Rz;Lk; 
tiu ntapypy; itj;Jf; fOTf. ,t;tpjk; MWKiw nra;a mak; 
Rj;jpahk;. 
 maj;jpw;F Itifj; Njhlq;fs; cz;nld;Wk;> mtw;iw ePf;Fk; 
tif ,d;dntd;Wk; $wg;gl;bUf;fpd;wJ. mjidf; fPo;tUk; 
nra;Al;fs; czHj;Jk;: 
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  ‘thWNf spUk;Gf;ifq; Fzq;f Sz;L 
   tifahfr; nrhy;YfpNwd; ed;wha;f; NfSk;: 
  jhWNfs; jpiurtpL Tilr;r Y}wy; 
   rurkh apUf;fhj Fze;jh ide;Jk; 
  NgWNf spijePf;f twpe;Njhd; thjp 
   gphpj;jpjid ePf;fhjhd; gpze;jhd; ghNu 
  thWNfs; Fsk;ntl;l T+w;Wg; Nghy 
   tk;kk;kh tpUk;G+wy; mUfh njd;Nd” 
  ‘mUfhj tpUk;G+w yWf;ff; NfSk; 
   milthd rhukpb yUF %wy; 
  jUfhj rtplWf;F rhw;wf; NfSk; 
   jaq;fhj fy;Yg;ghy; rtpL NghFk; 
  kUfhj jpiuNghf thpir NfSk; 
   tskhd tPukpbd; kzpNgh yhFk;. 
  cUfhj [Puzpg;Gg; Nghf ntd;why; 
   XNfhNfh #jkpl;Nl cUf;fpg; ghNu.” 
  ‘ghug;gh Tile;jnjd;why; ehdj; J}J 
   gUtKl dQ;Rf;Fk; gaDQ; nrhd;Ndd;.” 
 Rj;jp nra;ag;gl;l maj;ijg; gw;gk;> nre;J}uk;> fsq;F> nkOF> 
tlfk;> ghzpjk; Kjypa kUe;Jfshf;fp cgNahfpj;jy; Ntz;Lk;. 
,tw;Ws; 
  gw;gk;   - KOtd;ik 
  nre;J}uk;   - Kf;fhy; td;ik 
  kw;wkUe;Jfs;  - mjw;Ff; Fiwe;j td;ik 
nfhLf;Fk; vd;gij czHjy; Ntz;Lk;. 
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gw;g kfpik 
   ‘tPuj;J kpf;fit gw;gq;fNs - ghp 
    fhuj;J kpf;fit gw;gq;fNs 
   ghUf;Fs; khdplH Neha;Nghf - tU 
    gz;bjUf;nfy;yh khNkhfk; 
   tPuflhhp - gpzpf;nfhU 
    ghuFNlhhp - tpirngW 
    jPujlhhp - tpidAL 
   #hpf;FO Nenuhj;jJ 
    NkUf;fpid ghug;Gwk;” 
        - NjiuaH jU  
      - Fzghlk; jhJ - rPt tFg;G 
      By Dr. R. Thiyagarajan L.I.M. 
Kz;lNyh`j;jpd; Fzq;fs;: 
 ,uj;jj;ij tpUj;jp nra;Ak;. ,u]uj;d rKr;rak; (g.vz;:62) 
mak; NrUk; ghz;L Neha;f;fhd kUe;Jfs; 
1. Jthjr Nyhf khuz nre;J}uk;: - mD Nghf itj;jpa etePjk;     
msT   -1/2 -1 ½ Fd;wpkzp vil 
      Jiz kUe;J  - Njd;> nea;. 
2. fhuNyhfr; nre;J}uk;: - mD Nghf itj;jpa etePjk;         (g.vz;: 23) 
    msT   -1-2 Fd;wpkzp vil 
     Jiz kUe;J  - Njd;> nea;. 
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3.Rz;zNyhfr; nre;J}uk;: mD Nghf itj;jpa etePjk;        (g.vz;:30) 
     msT   - 1 ½ -3 Fd;wpkzp vil> 
     Jiz kUe;J  - Njd;> nea;> nts;shp tpij> fj;jphp tpij> 
Kyhk;gotpij> neUQ;rpKs;S ,tw;wpy; xd;wpd; rhW. 
4. mar;rj;J nre;J}uk;: mD Nghf itj;jpa etePjk;            (g.vz;: 32) 
     msT   - ¾ -1 ¼ Fd;wpkzp vil 
     Jiz kUe;J  - Njd;> nea;. 
5. ma nkOF: mD Nghf itj;jpa etePjk;        ( g.vz;: 33) 
     msT   - ½ ( 1 ¾ fpuhk; Kjy; 1 (3 ½ fpuhk;) tiu 
     JizkUe;J  - rHf;fiu> Njd;> nea;. 
6. mark;gPufw;gk;: mD Nghf itj;jpa etePjk;                    (g.vz;:35) 
     msT   - 1 tuhfd; (3 ½ fpuhk;) -2 tuhfd; (7 fpuhk;) 
   khj;jpiunadpy; 
     JizkUe;J  - Njd;> rHf;fiu> nea;. 
7. mar;#uzk;: mD Nghf itj;jpa etePjk;         (g.vz;: 36) 
     msT   - 10 - Fd;wpkzp vil> 
     JizkUe;J  - Njd;> nea;. 
8. mafhe;jhjp Fspif: mf];jpaH - 2000 %d;whk; ghfk;     (g.vz;: 80) 
     msT   - 1 khj;jpiu 
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9. fhe;j gw;gk;: mf];jpaH - 2000 %d;whk; ghfk;                ( g.vz;: 92) 
     msT   - 11 tuhfd; vil. 
     mDghdk;   - Njd; 
10. jhthf;fpdp gw;gk;: mf];jpaH-2000 %d;whk; ghfk;        (g.vz;: 366) 
      msT   - 3 ½ Fd;wp ,Untis> 
     mDghdk;   - Njd;. 
11.ghz;LthPurk;: mDgt itj;jpa Njtufrpak;                (g.vz;: 371) 
     msT   - 1-2 Fd;wpkzp gpukhzk; 
12.k`hrTghf;fpa Rz;b: mDgt itj;jpa Njtufrpak;      (g.vz;:379) 
13. v/F nre;J}uk;: mDgt itj;jpa Njtufrpak;       (g.vz;:380) 
      msT   -  ¼ -  ½  Fd;wp 2 Ntis 
      mDghdk;   - Njd; my;yJ nea;. 
14. mafhe;jr; nre;J}uk;: rpj;jitj;jpaj; jpul;L                (g.vz;: 132) 
      jf;f mDghdk; 
15. kfhuh[ kpUfhq;fk;: rpj;jitj;jpaj; jpul;L         (g.vz;: 63) 
      msT   - 1 khj;jpiu 
16. kfh tre;j FRkhfuk;: rpj;jitj;jpaj; jpul;L        ( g.vz;: 65) 
      msT   - 1 khj;jpiu 
      mDghdk;   - jphpgiyr; #uzk; 
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17. vYkpr;rq;fLF: mfj;jpaH itj;jpa rpe;jhkzp. - 4000  (g.vz;: 229) 
      msT   - ghjp vYkpr;ir      
18. fLf;fha; nea;: mfj;jpaH itj;jpa rpe;jhkzp. - 4000    (g.vz;: 286) 
19. magw;gk;: Fzghlk; - jhJ           (g.vz;: 93) 
      msT   - rhikahprp msT 
      mDghdk;   - jf;Nfhyhjpf;fsp. 
20. mar; nre;J}uk;: Fzghlk;  - jhJ          (g.vz;: 97) 
     msT   - rhikahprp msT 
     mDghdk;   - thiog;gok;. 
21. magpUq;fuh[ ghzpjk; : Fzghlk;  - jhJ                 (g.vz;: 103) 
22. jphpNyhfr; nre;J}uk; : Fzghlk;  - jhJ                     (g.vz;: 115) 
     msT   - gzntil 
      mDghdk;   - rQ;rPtp #uzj;jpy;> nea;apy; kj;jpj;Jz;z 
23. #rpfhguzk;: mfj;jpaH itj;jpa fhtpak; - 1500         (g.vz;: 737) 
     msT   - Njitahd msT 
24. mf;fpdpFkhhp: mfj;jpaH itj;jpa fhtpak; - 1500        (g.vz;: 786) 
     nfhk;kl;bf;fha; rhW> Fkhpr;rhW. 
25. tpl;LZ uhr G+gjp: mfj;jpaH itj;jpa fhtpak;-1500     (g.vz;:821) 
     msT   - Njitahd msT    
Jiz kUe;J  - ,Q;rp rhW. 
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26. Rakf;fpdpr; nre;J}uk;: mfj;jpaH gs;S - 200               (g.vz;: 26) 
 msT   - 1- 1 ½ Fd;wpnail 
 Jiz kUe;J  - Njd;> nea;> ntz;nza; Kjypait. 
27. tPu mar;nre;J}uk;: fz;Zrhkp guk;giuitj;jpak;        (g.vz;: 315) 
     msT   - ½ -1 Fd;wpnail. 
     mDghdk;   - Njd;> nea;> ntz;nza;. 
28. rj;Jr;nre;J}uk;: fz;Zrhkp guk;giuitj;jpak;;: 
     msT   - ¼ Fd;wp vil> ,UNtis 
29. G+uzre;jpNuhja rj;J nre;J}uk;:  
fz;Zrhkp  guk;giuitj;jpak;        (g.vz;: 344) 
msT   - 2-3 mhprpg;gpukhzk;.     
30. fl;Nyhfr; nre;J}uk;: fz;Zrhkp guk;giuitj;jpak;      (g.vz;:346) 
    msT    - 1-2 mhprp gpukhzk; 
    mDghdk;   - nty;yk;> ,UNtis 3-5 ehs; nfhLfTk;. 
31. ma jq;f nre;J}uk;: fz;Zrhkp guk;giuitj;jpak;       (g.vz;:358) 
    msT    - ½ -1 Fd;wpnail 
32. fUk;nghd; nre;J}uk;: rpNuhuj;jpd itj;jpa G+\zk;      (g.vz;: 48) 
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mak; NrUk; gpw Neha;f;fhd kUe;Jfs; 
1. kd;kjNyhf nre;J}uk; : mDNghf itj;jpa etePjk;         (g.vz;: 25) 
msT   - 2-3 Fd;wpkzp vil 
Jiz kUe;J  - thJik my;th> Njd;> nea;> ghNyL> ntz;nza; 
gad;    - cly; td;ik> Mz;ik cz;lhFk;. 
2. RtHzNyhf nre;J}uk;: mDNghf itj;jpa etePjk;         (g.vz;: 27) 
msT   - 2-3 Fd;wpkzp vil> 
Jiz kUe;J  - gad;> 
fhiyapy;   - 1 tuhfndil Njdpy; 
khiyapy;   - 1 tuhfndil mKjhjpnaz;nzapy; cz;zTk;. 
jPUk; Neha;fs;  - ra Neha;fs;> ,Uky; Neha;fs;. 
3. RtHzNyhfj; jpuhtfk;: mDNghf itj;jpa etePjk; (g.vz;: 40) 
msT   - 1(3 ½ fpuhk;) Kjy; 1 ½ (5 ¼ fpuhk;) tpuhfndil. 
JizkUe;J  - jpuhtfj;jpd; vilf;F 10 gq;F jz;zPhpy; fye;J      
  nfhLf;fyhk;. 
jPUk; Neha;   - NkfRuk;> FspHRuk;> jPuhj Ruk;> ehl;gl;lRuk;. 
4. fhe;jr;#uzk;: mf];jpaH 2000 %d;whk; ghfk; (g.vz;:169) 
msT   - %tpuy; nfhs;SksT> 
mDghdk;   - nea; 
jPUk; Neha;   - Fd;kk;. 
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5. gQ;rNyhf mQ;rdk;: mf];jpaH 2000 %d;whk; ghfk;      (g.vz;:357) 
msT   - ½  gawsT      
jPUk; Neha;   - glyk;> gpy;yk;> Fe;jk; Kjyhd fz;Nzha;fs;.  
mThpapiyr;rhw;wpy; ,l fz;jbg;Gfs; jPUk;. 
6. rpuRtj;jp mQ;rdk;: mf];jpaH 2000 %d;whk; ghfk;      (g.vz;:359) 
msT   - 1 gaw;wk; gUg;gsT jz;zPH tpl;L ,ioj;J ,l  
   Gifr;ry; jPUk;. ifahe;jfiur;rhw;wpy; ,l - ] 
   gw;gNuhfk; ghHit FiwTjPUk;. 
7. rq;fuiguturk;: mDgtitj;jpa Njtufrpak;               (g.vz;:344) 
msT    - Fd;wp vil 
mDghdk;   - jpg;gpyp#uzk;> Njd;. 
jPUk; Neha;fs;  - Uj;jh`rd;dp. 
8. mNahu[hjp #uzk;: mDgtitj;jpa Njtufrpak;          (g.vz;:383) 
mDghdk;   - Njd;> nea; my;yJ nty;yk;; ,tw;Wld;  
jPUk; Neha;   - fhkhiy. 
9. Mde;j igut khj;jpiu: rpj;jitj;jpaj; jpul;L          (g.vz;: 3) 
jPUk; Neha;   - rPjhq;frd;dp 
10. F\;lf[Nfrhp: rpj;jitj;jpaj; jpul;L                 (g.vz;: 13) 
mDghdk;   - rHf;fiu> Njd;. 
jPUk; Neha;   - F\;lk;> Nkfk;. 
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11. jphpNyhf ul;rhkzp: rpj;jitj;jpaj; jpul;L                (g.vz;: 27) 
msT   - Fd;wpasT 
jPUk; Neha;   - Nkfk;> \ak;> jhJ\Pzk;  
12. matPunre;J}uk;: Fzghlk; - jhJ         (g.vz;: 73) 
msT   - Fd;wpkzpasT 
mDghdk;   - gidnty;yk; 
jPUk; Neha;   - #iy> F\;lk;> thjePH> tp\f;fb.  
13. nrhHdhg;gpufr; nre;J}uk;  Fzghlk; - jhJ              (g.vz;: 394) 
mDghdk;   - rpe;jpyhjp Nyfpak; 
jPUk; Neha;   - NkfePhpopT 21-f;Fk; rpwe;jJ. 
14. Fz;lyhjp Nyfpak ;: mfj;jpaH itj;jpa rpe;jhkzp 4000 (g.vz;:245) 
jPUk; Neha;   - thjf;fl;L> #iy> twl;rp> ,jaNeha;> 
15. ,urG+gjp: mfj;jpaH itj;jpa rpe;jhkzp 4000              (g.vz;:350) 
msT   - cSe;jsT 
jPUk; Neha;   - thj Ruk;> gpj;j Ruk;> NjhlRuk;. 
16. etNyhf mf;fpdpFkhud;:mfj;jpaH itj;jpa rpe;jhkzp 4000   
       (g.vz;:351) 
msT   - Fd;wpasT       
jPUk; Neha;   - mjpfRuk;> MkRuk;> rd;dpghjRuk;> jhe;jphpf rd;dp 
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17. cj;jkhf;fpdpFkhud;: mfj;jpaH itj;jpa rpe;jhkzp 4000  
     (g.vz;:350) 
msT   - cSe;jsT     
jPUk; Neha;   - thj> gpj;jrd;dp> Ruk;.  
18. rlhl;ruFkhhp nre;J}uk;:mfj;jpaH itj;jpa fhtpak; 1500  
    (g.vz;: 690) 
msT   - gzntil> 1 kz;lyk; tiu.      
mDghdk;   - jphpfLfk;> Njd;fye;J. 
jPUk; Neha;   - thjk;> thA> ml;lFd;kk;> rd;dpthjk;> gpj;jk;> 
   rpNyl;Lkk;> Kay;typ> Fjpiutyp> neQ;Rtyp. 
19. rk;gpujhar; #uz gw;gk;: mfj;jpaH itj;jpa fhtpak; 1500  
(g.vz;:736) 
msT   - Ntz;ba msT      
jPUk; Neha;fs;  - Fd;kq;fs; vl;Ltif> fpuhzp>  mf;fpdpke;jk;>  
  midj;Jk; jPUk;. 
20. ,uhrkNfRuk; Fspif: mfj;jpaH itj;jpa fhtpak; 1500  
(g.vz;: 790) 
msT   - Fd;wpnail       
JizkUe;J  - Njd; 
jPUk; Neha;fs;  - rpNyl;Lk Fd;kk;> vYk;GUf;fp> Fd;kk;> 
     nrhpahik> Fly;thjk;> tapw;WNeha;. 
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MATERIALS AND METHODS 
 In this dissertation the GANDAGA CHENDURAM was taken as a 
compound drug study. This drug was prepared as per to specification 
given in Bogar 700 Page No.51 
COLLECTION OF THE TESTED DRUGS: 
 Gandagam (sulphur) and Iron was bought from raw drug store at 
Government Siddha Medical College Palayamkottai. 
PURIFICATION OF SULPHUR: 
 Impured sulphur is put into the steel bowl and mixed into the cow’s 
butter becoming melting and then dipped into cow’s milk. This process is 
repeated for 30 times & to get purified sulphur. Fresh milk can be used in 
every washing. 
PURFICATION OF IRON: 
 Impured iron is put into the furnace and then boiled upto the red 
discolouration and dipped it into the vinegar, sesamum oil, cow’s urine 
and decoction of Dolichos biflorus (Horse gram) upto 3 times 
respectively and washed it in a freshwater for every process. 
INGREDIENTS: 
• Purified sulphur 
• Purified Iron 
• Water of Limestone. 
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PREPARATION OF THE TESTED DRUG (GANDAGA CHENDURAM): 
 1575 grams of purified sulphur and 525 grams of purified iron is 
put into the appothekaric mortar & pestle (Kalvam). It was ground with 
the water of limestone for 7 days and then placed it in a pot which is 
made in an earthern ware and then burnt it. The melting process 
continues, till the smoke will ceased and to get the gandaga chenduram. 
The end product (Gandaga Chenduram) is reddish black in colour.  
DOSE: 
 500 mg along with honey, twice a day before meals. 
ROUTE OF ADMINISTRATION: 
 Enteral route 
 This prepared Gandaga chenduram used for the following 
methods 
 Bio - Chemical analysis 
 Pharmacological analysis 
 Toxicity study  
 Geochemical analysis 
 Anti Microbial analysis  
 Clinical assessment 
 Bio Statistical analysis.  
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BIO – CHEMICAL ANALYSIS OF GANDAGA 
CHENDURAM 
PREPARATION OF THE EXTRACT  
100mgs of chenduram is weighed accurately and placed into a 
clean beaker and added a few drops of concentrated HCL and evaporated 
it well.  After evaporation cooled the content and added a few drops of 
conc.  Nitric acid and evaporated it well.  After cooling the content add 
20ml of distilled water and dissolved it well.  Then it is transferred to 
100ml volumetric flask and made up to 100ml with distilled water.  Mix 
well Filter it. Then it is taken for analysis.  
TABLE : 2.5 QUALITATIVE ANALYSIS OF GANDAGA 
CHENDURAM 
S.No EXPERIMENT OBSERVATION INFERENCE 
1. Test for Calcium : 2ml of 
the above prepared extract is 
taken in a clean test tube. 2ml 
of 4% Ammonium oxalate 
solution is added to it.  
A white 
 precipitate is 
 formed  
Indicates the 
 presence of 
 calcium.  
2. Test for Sulphate: 2ml of the 
extract is added to 5% barium 
chloride solution 
A white 
 precipitate is 
 formed  
Indicates the 
 presence of 
 sulphate 
3. Test for Chloride : The 
extract is treated with silver 
nitrate solution 
A white 
 precipitate is 
 formed  
Indicates the 
 presence of 
 Chloride.  
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4. Test for Carbonate : The 
substance is treated with 
concentrated HCL. 
No brisk 
 effervessence is 
 formed   
Absence of 
 Carbonate.  
5. Test for Zinc : The extract is 
added with potassium ferro 
cyanide solution .  
No white 
 precipitate is 
 formed  
Absence of Zinc
6. Test for Iron – Ferric : The 
extract is treated with 
concentrated Glacial acetic 
acid and potassium ferro 
cyanide. 
Blue colour is 
 formed  
Indicates the 
 presence of 
 ferric Iron.  
7. Test of Iron Ferrous:  The 
extract is treated with 
concentrated Nitric acid and 
ammonium thio- cyanate.   
Blood red colour 
is formed  
Indicates the 
 presence of 
 ferrous Iron.  
8 Test for Phosphate: The 
extract is treated with 
ammonium Molybdate and 
concentrated nitric acid.  
No yellow 
 precipitate is 
 formed  
Absence of 
 Phosphate.  
9. Test for Albumin : The 
extract is treated with 
Esbach’s reagent.  
No Yellow 
 precipitate is 
 formed  
Absence of 
 Albumin. 
10. Test for Tannic Acid: The 
extract is treated with ferric 
chloride. 
No blue black 
precipitate is 
 formed 
Absence of 
 Tannic Acid.  
11. Test for Unsaturation : 
Potassium permanganate 
solution is added to the 
extract.  
It gets 
 decolourised 
Indicates the 
 presence of 
 unsaturated 
compound.   
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12. Test for the Reducing 
Sugar:  5ml of Benedict’s 
qualitative solution is taken in 
a test tube and allowed to boil 
for 2 mts and added 8-10 
drops of the extract and again 
boil it for 2 mts.  
No Colour change 
occurs.  
Absence of 
 Reducing 
Sugar.  
13. Test for Amino Acid :  One 
or two drops of the extract is 
placed on a filter paper and 
dried it well.  After drying 
1% Ninhydrin is sprayed over 
the same and dried it well.  
No violet colour is 
formed  
Absence of 
Amino acid.  
 
Inference: 
The given sample of drug GANDAGA CHENDURAM Contains 
calcium, sulphate, chloride, ferric-iron, ferrous iron & unsaturated 
compound.  
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GEO-CHEMICAL ANALYSIS 
METHODOLOGY FOR ANALYSIS OF METALS 
BY ATOMIC ABSORPTION 
SPECTROMETER  
PRINCIPLE: 
 Atomic absorption is the process that occurs when a ground state 
absorbs energy in the form of light of a specific wavelength and is 
elevated to an excited state.  The amount of light energy absorbed at this 
wavelength will increase as the number of atoms of the selected element 
in the light path increase.  The relationship between the amount of light 
absorbed and the concentration of analytes present in known standards 
can be used to determine unknown sample concentration by measuring 
the amount of light they absorb.  
 The absorption of light is proportional to the concentration of free 
atoms in the flame is given by Lambert-beer law.  
Absorbance = log 10 l0/lt=k.c.l 
Where,  
 l0 = intensity of incident radiation emitted by the light source. lt = 
intensity of transmitted radiation.  c=concentration of sample (free atoms) 
k=constant, l = path length.  
METHODOLOGY FOR METAL ANALYSIS 
a)  SAMPLE COLLECTION:  
 The dried samples will be grinded and powdered in an agate pestle 
and mortar.  Samples will be labeled and stored in pre-cleaned 
polyethylene bottles for further analysis.  
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b)  REAGENTS AND APPARATUS:  
 All the reagents such as HCL & HNO3 purchased from MERCK 
(Analytical Grade).  Millipore water will be used for all analytical work 
and all the glassware’s Polyethylene bottles, Pipette tips and others will 
be washed with 1% HCL, rinsed with de-ionized water before preparing 
standards, reagents and samples.  
c)  DIGESTION OF SAMPLES (SAMPLE PREPARATION):  
 A Multiwave 3000 micro oven system (from Anton paar, USA) 
with 16 position Teflon vessels with capping is being used here.  The 
digestion vessels are provided with a controlled pressure, temperature and 
release valve.  Before use, all Teflon vessels are soaked with 10% HNO3.   
The system is initially programmed by giving gradual rise of 20%, 40% 
and 50% power for 5, 15 and 20 minutes respectively for the due 
warming up.  The powder samples are being used without any further 
treatment for sample preparation.  0.1 g of sample is weighed into the 
Teflon vessels followed by digestion mixture of HCL & HNO3in the 
ration of 3:1 
 The resulting solution after microwave digestion is filtered through 
whatman # 40 filter paper (if necessary) and diluted to 50 ml with de-
ionized water.  A sample blank containing only acid mixture is prepared 
at the same time.  The method of standard addition is generally adapted to 
calibrate the instrument before going for the observation of the samples.  
DETERMINATION OF METALS:  
 All the atomic measurements are carried out with Perkin Elmer 
model 400/HGA900/AS800 coupled with Mercury Hydride System -15 
(MHS -15).  The lamps of Hallow cathode Lamp (HCL) for Fe, Cu, Mn, 
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Zn, Ni, Co and Electrode less Discharge Lamp (EDL) for Cd, Pb, Hg & 
As analysis are used as a light source to provide  specific wavelength of 
the elements to be determined and high purity (99.999%) Acetylene, 
Nitrous oxide are used to provide constant thermal energy for atomization 
process and Argon gas used for carrier gas purging purposes for Graphite 
furnace.  
CALIBRATION OF INSTRUMENTS: 
 More than three working standard solution of elements to be 
determined are prepared, covering the concentration range as 
recommended by the manufacturer of the instrument for the elements to 
be determined.  Before the analysis of samples, the instruments will be 
calibrated with prepared working standard solution.  The calibration 
curves will be obtained for concentration vs. absorbance data statistically 
analyzed.  Calibration of the instrument will be repeated periodically 
during operations and blanks will be carried with each set of 10 samples 
or aspirate any one of the prepared working standard for every 10 
samples to check the instrument drift and to validate analytical 
procedures and performance.  Reagent blank reading will be taken and 
necessary correction will be made during the calculation of concentration 
of various elements.  
FE,CU,MN,ZN,CD,PB,CO,&NI ETC., METALS ANALYSIS 
(FLAME AAS / GRAPHITE FURNACE)  
 After calibrating the instrument with prepared working standard, 
the digests liquid sample’s solution is subjected to analysis of Fe, Cu, 
Mn, Zn, Ni Co by AAS flame and As by furnace with specific 
instrumental conditions as given by instruments manufacturer.  Introduce 
the solution into flame, record the reading, using the mean of the three 
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reading and quantified the concentration of the metals in the given 
samples against the standard calibration curve obtained from 
Concentration vs.  Absorbance of the prepared known concentration on 
the day of the analysis.  
HG ANALYSIS BY COLD VAPOUR METHOD:  
 After Calibrating the instrument with prepared working standard, 
the 10ml of digests liquid sample’s pipette out to a specific container of 
Mercury Hydride system analyzer followed by adding 1.5% of HCL of 10 
ml as diluents for each flask and blank, 3% of NaBH4 solution in 1% of 
NaOH is run through the reaction flask to quartz cell with out heating 
against the calibration curve obtained from concentration vs. absorbance 
of the prepared known concentration on the day of the analysis.  
 
 
 
 
 
 
 
 
  115
CENTRE FOR ADVANCED RESEARCH IN INDIAN SYSTEM OF 
MEDICINE 
(CARISM) 
SASTRA UNIVERSITY, THANJAVUR – 613 402. 
 
Metals Analysis Report  
 
Authorised Drug Testing Laboratory Approved By The Drug 
Controller, Govt. of Tamil Nadu.  
 
 
Instrument used : Atomic Absorption Spectrometer A Analyst 
400/HGA900/AS800/MHS 15.  
 
Units in ppm  
TABLE : 2.6 HEAVY METAL ANALYSIS 
Sample 
Name 
Fe Cu Mn Zn Ni Co Cr Cd Pb Hg As 
Gandaga 
Chenduram  
12.640 8.6125 7.7350 2.4950 0.4242 0.0875 1.9700 0.0128 0.9545 0.1971 0.3955 
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PHARMACOLOGICAL ANALYSIS  
PHARMACOLOGICAL ANALYSIS OF TRIAL MEDICINE:  
 Study of the haematinic effect of Gandaga Chenduram on 
Albino rats.  To prove its haematinic effect of which Gandaga 
Chenduram an attempt was made to study its effect using “Albino rats”.  
For this purpose rats are made anaemic by the following procedure.  
ARTIFICIALLY INDUCED IRON DEFICIENCY : 
 The albino rats taken for this experiment were kept in an 
aluminium cages and provided with drinking water and milk, free from 
iron. The administration of the iron preparation under investigation was 
started when the haemoglobin level fell to 6-6.5 gram/100ml.  At the 
beginning of the experiment Hb mg% were determined.  
STUDY ON RATS:  
 The albino rats were first divided into 2 equal groups with five rats 
in each group the first group received Gandaga Chenduram 20mg/100 gm 
of body weight with honey.  The second group received normal diet.  All 
the above procedures were continued for five weeks in once a day the 
haemoglobin levels of rats were measured, I, II, III, IV, V weeks.  The 
results observed are tabulated in the following chart.  
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TABLE : 2.7 STUDY OF HAEMATINIC EFFECT OF USING THE 
DRUG OF GANDAGA CHENDURAM  
S.No Drugs Initial 
Reading 
After Drug Administration Remarks 
1st  
Week 
2nd
Week 
3rd
Week 
4th
Week 
5th 
Week 
1 
 
 
 
 
 
2 
 
 
 
 
Control 
(Water)  
 
 
 
 
Test Drug 
Gandaga 
Chenduram 
5.6 gm 
5.8 gm 
6.4 gm 
6.6 gm 
6.7 gm 
6.0 gm 
5.8 gm 
6.0 gm 
5.9 gm 
6.2 gm 
6.5 gm 
6.1gm 
5.6 gm 
5.8gm 
6.4 gm 
6.6 gm 
6.7 gm 
6.0gm 
6.2 gm 
6.5 gm 
6.5 gm 
6.6 gm 
7.0 gm 
6.8 gm 
5.5gm 
5.6gm 
6.2gm 
6.5gm 
6.6gm 
6.0gm 
7.0gm 
7.2gm 
7.2gm 
7.4gm 
7.6gm 
7.3gm 
5.3gm 
5.4gm 
6.0gm 
6.4gm 
6.4gm 
5.7gm 
8.0gm 
8.4gm 
8.2gm 
8.5gm 
8.5gm 
8.2gm 
5.2gm 
5.2gm 
5.7gm 
6.0gm 
6.1gm 
5.4gm 
9.2gm 
9.5gm 
9.5gm 
9.7gm 
9.8gm 
9.3gm 
5.0gm 
5.0gm 
5.3gm 
5.7gm 
5.7gm 
5.0gm 
11.0gm 
11.5gm 
11.5gm 
11.7gm 
11.6gm 
11.3gm 
Average 
5.3gm 
 
 
 
 
11.4 gm 
 
Result: 
This table shows that the test drug Gandaga Chenduram has got 
significant haematinic action.  
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TOXICITY STUDY OF “GANDAGA CHENDURAM” 
 This result is taken from the studies, conducted at the Centre for 
Advanced Research in Indian system of Medicine, SASTRA University, 
Thanjavur, during the year 2008. 
STUDY PATTERN:  
 Acute toxicity study was carried out using fresh wistar albino rats 
with either sex.  The animals were used for four months old with more or 
less equal weights.  
ACUTE TOXICITY STUDY: 
 The research work was carried out in the animal house attached to 
the Centre for Advanced Research in Indian system of Medicine, 
SASTRA University, Thanjavur, during the year 2008. 
SELECTION OF ANIMALS:  
 Fresh animals were selected for the experiment.  They were 
isolated and made accustomed to the laboratory conditions.  10 rats were 
selected and divided into 5 groups, each group consisting of 2 rats.  
DOSE LEVELS: 
 Group I  : 100mg/animal.  
 Group II : 200mg/animal 
 Group III : 400mg/animal 
 Group IV : 800mg/animal 
 Group V : 1600mg/animal 
Route of administration : Oral.  
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PREPATIONS OF THE TEST DRUG (GANDAGA CHENDURAM) 
FOR ADMINISTRATION . 
 The drug was weighted and suspended with equal quantity of 
lemon juice.  It was ground well and administered.  The preparation was 
done in such a way, so as 1ml of the suspension contained 400 mg of the 
drug.  
 The drug was administered once in the morning and observed.  
OBSERVATIONS: 
 The following details were recorded before the beginning of drug 
administration.  
 Body weight of animals. 
 Haematological investigation.  
 The above parameters were recorded upto 14 days and the results 
were tabulated below the table.  
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TABLE : 2.8 ACUTE TOXICITY STUDY – HAEMATOLOGY 
RESULTS  
Drug : Gandaga Chenduram.  
S.No. Parameters Pre-treament Pre-treament 
  G1 G2 G3 G4 G5 G1 G2 G3 G4 G5 
1. Total count 
(TC) Cells/Cu 
mm 
7600 7400 7000 6800 7100 7700 7900 7300 9100 8600 
2 Differential 
count (DC) 
          
 Neutrophils 31 33 37 40 43 29 34 4\32 36 38 
 Lymphocytes 67 63 600 60 54 64 63 64 64 62 
 Monocytes - - - - - - - - - - 
 Eosinophils 2 4 3 - 3 7 3 4 - - 
3 Haemoglobin 
(Hb) gm/dl 
11.8 12.0 11.8 11.4 12.0 12.0 12.2 12.0 12.2 12.8 
4 RBC 
Morphology 
Normocytic Normochromic and No immature cells seen 
5 Weight of the 
animal (gm) 
125 140 135 140 125 130 140 135 130 125 
 
Result :   
The heamatology profile of Gandaga Chenduram treated rats reveal 
normal findings.  No abnormalities / No significant pathology. 
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Processing for Histopathological study: 
 The tissue samples were collected for the histopathological study.  
The study report was given by Dr.G.Victor Rajamanickam Ph.D. at 
Advanced research in Indian System of Medicine, SASTRA, Thanjavor.  
 The tabular column shows in tested parameters and changes in 
histopathological specimen work also documented.  
Result: 
LD50 – 1600 mg/ animal 
 The single oral dose upto 1600 mg / animal of Gandaga 
Chenduram did not produce any mortality, even within 24 hours and upto 
14 days of drug administration. No significant haematological changes 
occurred.
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ANTI-MICROBIAL (BACTERIAL) ACTIVITY OF  
GANDAGA CHENDURAM  
AIM: 
 To identify the anti-microbial (Bacterial) activity of Gandaga 
Chenduram against Streptococcus, Staphylococcus, proteus, 
Pseudomonas, E.coli and Klebsiella. 
METHOD : Kirby Bauer Disc Diffusion Method 
MEDIUM : Mueller Hinton agar 
COMPONENTS OF MEDIUM: 
• Beef extract   : 300gms /lit 
• Agar    : 17gms /lit 
• Starch   : 1.50gms /lit 
• Casein Hydroxylate : 17.50gms /lit 
• Distilled Water  : 1000 ml 
• pH     : 7.6 
 
PROCEDURE: 
 The media was prepared from the above components and poured 
and dried on a Petri dish.  The organism was streaked on the medium and 
the test drug (1 gm drug in 10 ml of Water) was placed on the medium. 
This is incubated at 370C for one over night and observed for the 
susceptibility shown up clearance around the drug.  
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TABLE : 2.9 ANTI-MICROBIAL SUSCEPTIBILITY TEST 
REPORT 
No. Organism Susceptibility Zone of inhibition in mm
1. Staphylococcus Moderately Sensitive 10mm 
2. Pseudomonas Resistant - 
3. E. coli Resistant  - 
4. Klebsiella Resistant - 
5. Proteus Resistant - 
6. Streptococcus Resistant - 
 
RESULT: 
  The test drug Gandaga Chenduram was Moderately Sensitive 
against Staphylococcus. 
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CLINICAL ASSESSMENT OF GANDAGA CHENDURAM 
 Anaemia is the most common disorder of the blood.  Anaemia is 
defined as a qualitative or quantitative deficiency of haemoglobin, a 
molecule found inside red blood cells (RBCs).  Since haemoglobin 
normally carries oxygen from the lungs to the tissues, anaemia leads to 
hypoxia (lack of oxygen) in organs.  Since all human cells depend on 
oxygen for survival, varying degrees of anaemia can have a wide range of 
clinical consequences.  Anaemia is caused by the lack of iron in the body 
as well.  
 A clinical trial on Pandu Noi was carried out at the Government 
Siddha Medical College Hospital, Palayamkottai.  
 30 cases with full clinical data was recorded and they were 
diagnosed on the basis of Siddha Principles (Mukkuttram, envagai 
thervu) and modern clinical aspects.  
 Clinically the patients were selected as Pandu Noi according to the 
following including and excluding criterias.  
CRITERIA SELECTED FOR STUDY  
CRITERIA FOR INCLUSION : 
¾ Pallor of conjunctiva and nail beds. 
¾ Anorexia 
¾ Ulceration of mouth 
¾ Diarrhoea 
¾ Lassitude  
¾ Emaciation.  
¾ Palpitation 
¾ Dyspnoea on exertion.  
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CRITERIA FOR EXCLUSION  
¾ Chronic liver diseases 
¾ Chronic renal diseases 
¾ Myxoedema 
¾ Thalasemia. 
CLINICAL PATHOLOGICAL EXAMINATION  
BLOOD TEST:  
 Total count 
 Differential count 
 Haemoglobin 
 Erythrocyte sedimentation rate 
 Blood sugar 
 Blood urea 
 MCV- Mean corpuscular volume 
 PCV-packed cell volume 
URINE EXAMINATION : 
 Albumin 
 Sugar 
 Deposits 
MOTION EXAMINATION : 
 Ova 
 Cyst 
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DRUG AND DOSAGE : 
The drug Gandaga Chenduram was administered orally in a dose 
of 500 mgm twice a day along with honey before food.  
DIET AND MEDICAL ADVICE: 
• Rich iron content of foods especially green leafy vegetables.  
• Fruits, Meats, Sea foods, Nuts, Cereals, Eggs. 
• Fibre diet to prevent constipation.  
OBSERVATION:  
 The result was observed on the basis of the symptomatic relief 
obtained by the patients.  Out of 30 cases 11 were males and the 
remaining 19 were females with the age ranging from 16 to 62.  
RESULT:  
 Out of the 30 cases administered with Gandaga Chenduram 26 
cases (86.67%) showed good response, 3 cases (10%) showed fair 
response and remaining 1   case (3.33%) showed poor response.  
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BIO-STATISTICAL ANALYSIS 
STUDY ON THE EFFECTIVENESS OF GANDAGA 
CHENDURAM IN REDUCTION OF PANDU NOI   
 
 The clinical trials were described by mean, standard deviation and 
percentages. The study variables were analysed by mean and standard 
deviations.  The analysis of study variables and the effectiveness of drugs 
were interpreted by the students paired ‘t’ test.  The above analysis and 
inter preations were performed by the statistical Package S.P.S.S. (13.0) 
at the 5% level of significance. (P=0.05). 
Results and discussions: 
Gandaga Chenduram on Pandu  
Description of the study subjects  
 The study subjects were described according to their sex and age.  
The results were furnished in the below table.  
TABLE : 2.10 AGE AND SEX WISE DISTRIBUTION OF STUDY 
SUBJECTS. 
S.No. Age group 
Male Female Total 
No. % No % No % 
1 15-19 0 0 2 10.5 2 6.7 
2 20-24 1 9.1 0 0 1 3.3 
3 25-29 0 0 1 5.3 1 3.3 
4 30-34 1 9.19 3 15.8 4 13.3 
5 35-39 0 0 3 15.8 3 10.0 
6 40-44 0 0 2 10.5 2 6.7 
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7 45-49 3 27.3 3 15.8 6 20.0 
8 50-54 3 27.3 1 5.3 4 13.3 
9 55-59 0 0 1 5.3 1 3.3 
10 60-64 2 18.1 3 15.8 5 16.7 
11 65-69 1 9.1 0 0 1 3.3 
 Total 11 100.0 19 100.0 30.10 100.0 
 Mean 48.7 40.5 43.6 
 Std deviation 12.8 13.5 13.6 
  ‘t’ value 1.633 
Population mean value @95% C.I.  31 to 58.2 
 Significance P>0.05  
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AGE AND SEX WISE DISTRIBUTION OF STUDY SUBJECTS
      
The above table - 2.10 shows the  mean age of male, female and 
total study subjects.  The male mean age was 48.7 ± 12.8  and the female 
mean age was 40.5 ± 13.5.  The two mean values gave the meaning of 
females were lower than males.  But the remaing was not proved 
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statistically.  The sestets were having to same age (t=1.633, d:f=28 and 
P>0.05).  The total subjects mean age was 43.6 ± I 13.6.  The estimated 
population mean at 95% confidence interval was in between 31 to 56. 2 
years.  
Effectiveness of Gandage  Chenduram  Pandu Noi.  
 The effectiveness of the drug was assessed by recording the 
haemoglobin before starting the treatment and after at the end of the 
treatment.   
TABLE – 2.11  THE BEFORE AND AFTER MEAN 
HAEMOGLOBIN LEVEL. 
S.NO Study 
variable 
No of 
patients  
Before After Mean 
difference 
‘t’ d.f Significan
ce 
Mean S.D Mean S.D 
1 Haemoglobin 30 8.9447 0.78 10.83 0.71 1.89 14.327 29 P<0.0001 
 
The above table 2 clearly shows the effectiveness of   the drug increasing 
the haemoglobin  level.  The mean Hb before treatment was 8.9447 ±  
0.78 and after at the end of the treatment, the mean Hb was 10.83 ±  0.71.  
The difference between the mean was 1.89.  This increase of Haemglobin 
level was attributed the effectiveness of Gandaga Chenduram (t=14.327, 
d.f.=29 and P<0.0001). 
Response of the drug: 
 The response of the drug was studied by prognosing as good, fair 
and poor.  The results are placed as follows.   
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TABLE : 2.12  RESPONSE OF GANDAGA CHANDURAM IN 
CURING PANDU NOI. 
 
SI.No 
Prognosis
No of 
patients 
% 
1 Good 26 86.7% 
2 Fair 3 10.7 
3 Poor 1 3.3% 
 Total 30 100.0 
 
ILLUSTRATING THE PROGNOSIS 
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 The prognosis of the drug showed in the table - 3 illustrates the 
response of the drug.  The good response was observed in 86.7% patients.  
Only 10.7%, 3.3% were showed fair and poor response respectively from 
the above results and discussions  the hypothesis “GANDAGA 
CHENDURAM” was significant by and curing the diseases PANDU 
was accepted.    
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TABLE : 13  ILLUSTRATING THE SEX DISTRIBUTION  
Sl. No Sex No.of Patients Percentage 
1. Male 11 36.67% 
2. Female 19 63.33% 
 Total 30 100% 
 In males, about 1mg of iron is excreted everyday through feces.  In 
females, the amount of iron lost from the body is very much high.  This is 
because of the menstruation. 1gm of hemoglobin contains 3.34 mg of 
iron.  Normally 100ml of blood contains 15gm of hemoglobin and about 
50mg of iron (3.34x15).  So if 100ml of blood is lost from the body, there 
is a loss of about 50mg of iron.  In females, during every menstrual cycle, 
about 50ml of blood is lost and so about 25mg of iron is lost.  That is why 
the iron content of blood is always less in females than in males. 
ILLUSTRATING THE SEX DISTRIBUTION 
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OVERALL RESULTS OF TREATMENT 
86.67%
10%
3.33%
Good Fair Poor
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DISCUSSION 
DEFINITION ACCORDING TO SIDDHA TRADITIONAL 
TEXTS: 
 According to Siddha texts the disease “Pandu Noi” (Anaemia) is 
caused by the increase of Azhal Kuttram in food habits. It leads to 
nutritional deficiency in body, pallor of conjunctiva and nail beds, pain in 
legs due to a little walk, dyspnoea on exertion, anorexia, nausea, 
giddiness Fatigue, palpitation, Emasciation etc., 
ghz;L Neha; tUk; top: 
 ‘mwpe;JNk cw;gj;jp nrhy;yf; Nfsha; 
  mjprhu kykpsfp ve;Ne ue;jhd; 
 gpwpe;JNk GspAg;G ngUj;j yhYk; 
  ngj;jkh kf;fpdp apUj;j yhYk; 
 kpwpe;Jjhk; G+ykpf mUe;j yhYk; 
  kPwpNa kJf;fisj;jhd; Grpj;jyhYk; 
 gwpe;JNk gfy;epj;jpiu nra;j yhYk; 
  ghz;L te;J ghhpYs;NshH gLk;gh lhNk” 
 ‘ghlhd gQ;Rjidj; jpUb NdhHf;Fk; 
  ghq;fhd rptJfpiyg; gw;wp NdhHf;Fk; 
 khlhd gRtijg;gl; bdpa jhf 
  itf;fpd;NwhH kiwtopNa ele;jp lhjhH 
 fhlhd thuzpae; jdpw;top gwpj;Jf; 
  fLtijfs; nra;fpd;NwhH fz;fh zhj 
 Nfhlhd gopnrhy;ypf; Fbnf Lf;Fq; 
  nfhLk;ghtp ghz;Ltpdhw; Fjpnfhs; thNu.” 
        -Neha; ehly; Neha; Kjy; ehly; jpul;L (g.vz;:297) 
The above signs and symptoms are relieved clinically by the 
administration of the test drug (Gandaga Chenduram). The explanation is 
given below. 
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ACCORDING TO GUNAM: 
 In Gandaga chenduram, sulphur and Iron possess Astringent, sour 
and bitter taste. According to panchabootham theory Astringent, sour and 
bitter tastes are made up of 
  Astringent  - Earth + Air 
  Sour   - Earth + Fire 
  Bitter   - Air + Space 
 It has veppa veeriyam. Bitter and Astringent tastes are neutralized 
the pitha humour. 
ACCORDING TO ACTION: 
 The study of Gandaga chenduram having the following actions. 
 Alterative – to alters the morbid processes of nutrition and 
excretion restoring in some unknown way. 
 Nutrient – to nourishes the body as a whole. 
 Cordial (Improves blood) – Improves the quality of blood. 
 Stomachic – To stimulate exciting functional activity of the 
stomach. 
ACCORDING TO BIO-CHEMICAL ANALYSIS: 
 Iron is important for the formation of haemoglobin, myoglobin and 
other substances like cytochrome, cytochromedase, peroxidase and 
catalase. 
ACCORDING TO PHARMACOLOGICAL ANALYSIS: 
 The study of the Gandaga chenduram has got significant 
haematinic activity. 
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ACCORDING TO ACUTE TOXICITY STUDY: 
 There is no signs and symptoms of toxic effects. 
ACCORDING TO HEAVY METALS ANALYSIS: 
 Gandaga Chenduram contains 
Fe - 12.640 ppm  Cr   - 1.9700 ppm 
Cu - 8.6125 ppm  Cd   - 0.0128 ppm 
Mn - 7.7350 ppm  Pb   - 0.9545 ppm 
Zn - 2.4950 ppm  Hg   - 0.1971 ppm 
Ni - 0.4242 ppm  As   - 0.3955 ppm 
Co   - 0.0875 ppm 
ACCORDING TO CLINICAL EVALUATION: 
 About 30 patients suffering from pandu Noi (Anaemia) in Govt. 
Siddha medical college hospital, Palayamkottai revealed that the patients 
showed. 
 Good response - 86.67 % 
 Fair response - 10% 
 Poor response - 3.33% 
ACCORDING TO BIO- STATISTICAL ANALYSIS: 
 The tested drug Gandaga Chenduram has got significant effect 
in treating pandu noi. 
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SUMMARY 
 The tested drug Gandaga chenduram has been selected for the 
study to establish its efficacy in treating pandu Noi. 
 Chemical and Gunapadam aspect of sulphur and Iron have been 
described. 
 Bio-chemical analysis shows that the test drug Gandaga 
Chenduram contains calcium, sulphate, chloride, ferric - Iron, ferrous 
iron, and unsaturated compound. 
 Pharmacological analysis shows that this drug has got significant 
haematinic activity. 
 According to acute toxicity study the test drug Gandaga chenduram 
showed no toxic effects. 
 Heavy metal analysis by AAS was also done. The values are below 
the range of WHO standard. 
 Clinical evaluation was carried out on 30 patients suffering from 
pandu Noi in Govt. Siddha medical college hospital, palayamkottai, 
revealed that the patients treated with Gandaga chenduram had obtained 
excellent improvement. 
 Bio-statistical analysis also proved that this drug has got significant 
effect in treating pandu noi. 
 This may showed that the tested drug Gandaga Chenduram had 
potent action in relieving the signs and symptoms of pandu noi which 
can be compared to iron deficiency anaemia. 
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CONCLUSION 
 With these results it can be concluded that the tested drug 
Gandaga Chenduram had showed excellent results in relieving the 
signs and symptoms of the patients suffering from Pandu Noi. 
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